Diseases of the digestive system

K11_OTHDIG

dumping syndrome: Gastrointestinal symptoms resulting from an absent or nonfunctioning pylorus.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K90-K93 Cause of death: ICD-10 — K90-K93 2 out of 7 registries used, show all original rules.	26460
4. Check minimum number of events None	26460
5. Include endpoints K11_COELIAC K11_MALABSORB K11_POSTOPDIS K11_GIBLEEDING K11_OTHDISDIG K11_DISDIGINOTH	27676
6. Filter based on genotype QC (FinnGen only)	24653

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF12

NAME	K11_OTHDIG
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K11_COELIAC\|K11_MALABSORB\|K11_POSTOPDIS\|K11_GIBLEEDING\|K11_OTHDISDIG\|K11_DISDIGINOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K9
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K9
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diseases of the digestive system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	213210	101910	109178
Only index persons	168685	82909	85776
Unadjusted period prevalence (%)
Whole population	2.98	2.92	3.05
Only index persons	3.16	3.05	3.27
Median age at first event (years)
Whole population	63.29	65.41	61.20
Only index persons	60.72	61.91	59.58

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	24653	11858	12795
Unadjusted period prevalence (%)	5.07	4.21	5.87
Median age at first event (years)	61.92	57.44	66.08

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
25455: Matched controls
252550

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A02BC05

ATC

esomeprazole; systemic

1.7

323.0

10075

70921

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.4

320.5

1215

3680

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

318.0

4699

26583

WX892

NOMESCO Finland

Monitored bed care

2.4

316.4

2381

10384

A02BC03

ATC

lansoprazole; oral

1.7

310.9

7339

47816

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

308.8

8716

59581

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.2

308.7

1309

4244

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

307.7

3179

13733

L13.0

ICD-10 Finland

Dermatitis herpetiformis

16.6

307.7

307

186

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

18.4

307.7

1024

575

UJD02

NOMESCO Finland

Gastroscopy

4.1

307.7

2066

5367

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

10.8

307.7

538

506

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.0

307.7

1534

5287

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.4

307.7

4555

20788

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

7.8

307.7

559

722

K90.0

ICD-10 Finland

Coeliac disease

147.3

307.7

5540

476

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

5.5

307.7

862

1603

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

307.7

2495

10094

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.1

307.7

709

1189

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

307.7

6549

36686

N02AX02

ATC

tramadol; systemic, rectal

1.7

307.7

11217

79710

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

68.9

307.7

4733

834

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

13131

93103

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

7.5

307.7

15916

46040

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

307.7

5831

33451

WW500

NOMESCO Finland

Blood transfusion

3.5

307.7

1501

4470

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

307.7

5316

28142

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

307.7

5656

29802

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

6.2

307.7

2047

3537

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.1

307.7

3228

11153

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

1254.4

307.7

374

A02BC02

ATC

pantoprazole; systemic

2.5

307.7

19028

136858

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

18.4

307.7

656

362

K92.0

ICD-10 Finland

Haematemesis

353.8

307.7

4592

157

ZXD05

NOMESCO Finland

Urgent procedure

1.8

307.7

7940

51391

5781A

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[MELAENA]

+∞

307.7

426

K91.1

ICD-10 Finland

Postgastric surgery syndromes

165.8

307.7

199

R11

ICD-10 Finland

Nausea and vomiting

2.3

307.7

2692

12134

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.1

307.7

2262

7716

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

12.2

307.7

610

506

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

307.7

5215

28341

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

27.4

307.7

346

127

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

26.4

307.7

295

112

D64.9

ICD-10 Finland

Anaemia, unspecified

2.9

307.7

4548

17422

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

58.1

307.7

806

142

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

307.7

3146

13193

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

247.0

307.7

271

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

25.1

307.7

526

212

K90.9

ICD-10 Finland

Intestinal malabsorption, unspecified

144.0

307.7

484

UJF92

NOMESCO Finland

Capsular endoscopy

7.7

307.7

1193

1601

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

7.5

307.7

552

742

K92.9

ICD-10 Finland

Disease of digestive system, unspecified

52.2

307.7

682

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

9.0

307.7

981

1120

K26.4

ICD-10 Finland

Duodenal ulcer, chronic or unspecified with haemorrhage

15.2

307.7

314

208

UJF32

NOMESCO Finland

Coloscopy

3.4

307.7

10365

42571

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

307.7

2849

12495

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

307.7

10480

62820

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.9

307.7

2950

10892

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.6

307.7

1993

7868

C10AC01

ATC

colestyramine; oral

4.2

307.7

1088

2667

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

4.1

307.7

2606

6868

TPH07

NOMESCO Finland

Cathetrisation of artery

2.1

307.7

3416

17018

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

307.7

4636

19339

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

32.9

307.7

357

109

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.5

307.7

776

1059

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

23.4

307.7

349

150

K92.1

ICD-10 Finland

Melaena

95.5

307.7

10008

1702

C03CA01

ATC

furosemide; systemic

1.9

307.7

9675

61666

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

6.4

307.7

1271

2045

UJF30

NOMESCO Finland

Ileoscopy through colon

2.7

307.7

3477

14008

A02BC01

ATC

omeprazole; systemic

1.7

306.9

7206

46847

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

303.9

3350

17069

J01MA02

ATC

ciprofloxacin; systemic

1.6

300.9

10199

72956

A07EC02

ATC

mesalazine; oral, rectal

2.8

298.2

1590

5859

A06AD11

ATC

lactulose; oral

1.9

297.6

4462

25305

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

7.2

297.4

448

630

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

296.6

3473

18083

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

295.6

3492

18238

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.6

295.4

1007

2845

AA1AD

NOMESCO Finland

CT of head and brain

1.7

286.5

7879

53252

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.9

279.9

1378

4861

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

5.2

278.4

589

1156

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.0

278.1

824

2112

N02AA05

ATC

oxycodone; systemic

1.8

277.1

5228

31773

K90.8

ICD-10 Finland

Other intestinal malabsorption

56.9

272.2

154

K22.1

ICD-10 Finland

Ulcer of oesophagus

4.4

268.6

684

1565

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.9

267.7

1303

4566

5780A

ICD-9 Finland

Gastro-intestinal haemorrhage, Haematemesis

+∞

267.3

257

ZX120

NOMESCO Finland

Intravenous

2.2

265.4

2597

12601

UJF02

NOMESCO Finland

Peroral enteroscopy

9.4

265.1

319

342

A07EA06

ATC

budesonide; oral, local oral

3.1

261.2

1155

3832

R53

ICD-10 Finland

Malaise and fatigue

1.7

258.8

6699

44334

C03DA01

ATC

spironolactone; oral

1.9

257.9

3635

20112

JAH00

NOMESCO Finland

Laparotomy

3.4

255.6

957

2871

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.6

255.2

617

1354

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

255.1

6377

41789

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

254.5

4516

26865

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

253.4

7392

50389

H02AB06

ATC

prednisolone; systemic

1.6

251.5

11857

90462

F10.24

ICD-10 Finland

Alcohol depence active use

5.0

251.4

550

1111

K86.1

ICD-10 Finland

Other chronic pancreatitis

6.5

250.2

411

634

J01MA12

ATC

levofloxacin; systemic

1.8

247.6

4958

30532

A10AB05

ATC

insulin aspart; parenteral

2.2

243.3

2237

10572

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

9.3

237.4

286

307

5781B

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[HAEMORRHAGIA EX ANO]

+∞

233.0

224

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

231.5

6583

44395

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.1

231.1

653

1616

C07AB07

ATC

bisoprolol; oral

1.5

230.7

12492

97551

5790A

ICD-9 Finland

Intestinal malabsorption, Coeliac disease

+∞

229.8

221

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

12.2

229.6

230

189

B01AB05

ATC

enoxaparin; parenteral

1.6

228.9

7782

54765

JN4AD

NOMESCO Finland

Body CT examination

1.9

227.2

3185

17536

N06AX11

ATC

mirtazapine; oral

1.6

226.9

8236

58822

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

226.1

3961

23390

N05CF01

ATC

zopiclone; oral

1.6

224.0

8088

57654

P15

ICPC

Chronic alcohol abuse

3.3

224.0

888

2758

L04AX01

ATC

azathioprine; systemic

2.8

222.4

1200

4436

R06.0

ICD-10 Finland

Dyspnoea

1.6

222.3

6978

48120

P01AB01

ATC

metronidazole; oral, rectal

1.5

220.8

9085

66640

26910

ICD-8 Finland

Other nutritional deficiency, Malabsorption syndrome, unspecified

+∞

220.5

212

JFB00

NOMESCO Finland

Partial resection of small intestine

4.2

218.9

603

1464

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.5

218.1

1520

6368

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

9.4

217.1

260

277

D99

ICPC

Disease digestive system other

5.3

214.9

438

831

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.5

214.9

1376

5539

R50.9

ICD-10 Finland

Fever, unspecified

1.8

214.1

4031

24276

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

213.5

8206

59176

WX002

NOMESCO Finland

Sedation and analgesia

1.7

213.1

4766

30110

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

212.1

3002

16555

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

211.6

5628

37190

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.9

208.6

465

954

N03AX16

ATC

[U] pregabalin

1.6

206.9

5486

36193

K90.4

ICD-10 Finland

Malabsorption due to intolerance, not elsewhere classified

345.8

206.5

209

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.9

205.8

1016

3580

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.3

205.8

543

1276

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

204.1

4149

25502

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

203.3

2751

14935

A10AE04

ATC

insulin glargine; parenteral

1.9

199.2

2613

14032

N02BE01

ATC

paracetamol; systemic, rectal

1.7

197.1

21866

196477

K92.8

ICD-10 Finland

Other specified diseases of digestive system

12.7

196.9

192

151

A02BA02

ATC

ranitidine; systemic

1.7

195.4

4769

30747

N07BB01

ATC

disulfiram; oral

2.7

193.6

1086

4092

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

192.7

5274

34980

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.2

192.7

1759

8262

K55.8

ICD-10 Finland

Other vascular disorders of intestine

8.3

192.6

254

306

J01DB01

ATC

cefalexin; oral

1.6

192.6

19936

175262

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.3

192.4

756

2334

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.9

191.8

427

875

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

191.6

1071

4028

R4190

NOMESCO Finland

Nutritional therapy

2.6

191.2

1122

4324

SPAT1263

SPAT

Sampling

1.5

188.2

9924

75957

N05AH04

ATC

quetiapine; oral

1.7

187.9

4141

25961

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.8

187.8

592

1583

K70.1

ICD-10 Finland

Alcoholic hepatitis

7.5

187.4

271

364

A07AA11

ATC

rifaximin; oral

12.0

187.3

189

157

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

5.3

186.5

377

710

B82

ICPC

Anaemia other/unspecified

2.9

186.2

936

3329

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

185.7

2024

10171

TK800

NOMESCO Finland

Hemodialysis

3.4

184.9

685

2038

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.8

183.9

581

1556

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.2

182.2

1553

7090

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

180.9

1534

6987

SPAT1262

SPAT

Handing over of treatment supplies

1.7

180.4

4373

28077

K51.5

ICD-10 Finland

Left sided colitis

3.1

177.3

754

2440

N05BA04

ATC

oxazepam; oral

1.5

177.2

6232

43693

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.2

177.2

478

1142

R18

ICD-10 Finland

Ascites

3.5

177.1

639

1869

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

174.6

4066

25814

K70.4

ICD-10 Finland

Alcoholic hepatic failure

9.2

174.0

212

231

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.5

173.0

622

1815

D15

ICPC

Melaena

8.1

173.0

233

288

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.4

172.1

1311

5703

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

171.8

5982

41799

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

171.8

6891

49646

B01AA03

ATC

warfarin; systemic

1.6

170.3

5226

35478

RD210, ,

NOMESCO Finland

3.6

170.1

563

1556

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

169.8

1100

4445

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.5

168.3

603

1756

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

167.7

3622

22520

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.6

167.6

556

1539

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.6

167.6

1054

4199

T89

ICPC

Diabetes insulin dependent

2.6

165.8

1031

4085

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

165.7

8640

65521

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.8

164.8

378

794

B80

ICPC

Iron deficiency anaemia

2.9

163.5

773

2657

Z3231

NOMESCO Finland

Registered nurse

1.5

161.7

6561

47266

K29.7

ICD-10 Finland

Gastritis, unspecified

2.6

159.7

1001

3980

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.7

159.3

373

797

ZXE00

NOMESCO Finland

One hour or less

1.5

159.0

8884

68120

K91.8

ICD-10 Finland

Other postprocedural disorders of digestive system, not elsewhere classified

397.0

159.0

160

A11CC03

ATC

alfacalcidol; systemic

3.0

158.2

731

2480

J01FF01

ATC

clindamycin; systemic

1.5

157.6

6192

44268

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

157.5

2925

17421

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

157.1

1808

9247

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.7

156.6

365

777

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.7

155.5

838

3089

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

155.2

5005

34262

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

10.4

154.9

172

165

N06AB04

ATC

citalopram; systemic

1.6

154.5

4696

31714

K20

ICD-10 Finland

Oesophagitis

3.5

153.4

534

1526

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

153.0

1794

9232

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

3.0

152.1

698

2359

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

151.9

1594

7879

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

379.4

151.8

153

JN4BD

NOMESCO Finland

Extensive body CT

1.8

151.6

2547

14724

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

150.4

4025

26358

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

149.2

1605

8005

A10AC01

ATC

insulin (human); parenteral

1.9

148.5

1959

10494

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

148.4

3356

21065

M04AA01

ATC

allopurinol; systemic

1.7

148.0

3507

22276

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

147.8

772

2800

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

147.7

4476

30169

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

146.7

5716

40691

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

21.7

146.5

109

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

146.2

6663

48952

K50.8

ICD-10 Finland

Other Crohn disease

3.9

145.7

431

1102

A04

ICPC

Weakness/tiredness general

1.6

145.0

4014

26478

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

145.0

691

2385

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

144.7

1461

7115

Z3226

NOMESCO Finland

Physiotherapist

1.6

144.7

4197

27991

WX402

NOMESCO Finland

General anaesthesia

1.5

143.9

4993

34662

SPAT1254

SPAT

Administration of medicine

1.6

143.6

3828

25018

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

5.4

142.8

282

520

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

142.7

1144

5079

K29.2

ICD-10 Finland

Alcoholic gastritis

10.4

142.7

158

151

N05BA01

ATC

diazepam; systemic, rectal

1.7

142.7

3026

18660

SPAT1301

SPAT

No procedures

1.4

142.6

7437

56014

Z2446

NOMESCO Finland

Social worker

2.0

142.4

1587

8015

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

141.6

1862

9958

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

140.9

5814

41823

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.4

140.8

514

1514

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

140.4

3178

19928

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

139.8

2508

14761

A10AE05

ATC

insulin detemir; parenteral

2.1

139.7

1358

6517

N03AX12

ATC

[U] gabapentin; oral

1.6

139.2

3616

23467

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

138.2

9818

78032

R51.80

ICD-10 Finland

Headache

1.6

138.0

3412

21872

A28

ICPC

Limited function/disability NOS

1.5

137.7

4733

32747

B01AB10

ATC

tinzaparin; parenteral

1.7

137.0

2547

15138

I50.0

ICD-10 Finland

Congestive heart failure

1.8

136.9

2261

12984

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

136.4

8068

62061

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.3

136.3

357

834

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

135.5

752

2813

SPAT1255

SPAT

Intravenous administration of medicine

2.0

135.5

1685

8838

C07AA05

ATC

propranolol; systemic

1.6

135.4

4206

28447

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

20.7

134.5

102

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.1

133.7

561

1800

E86

ICD-10 Finland

Volume depletion

2.6

133.1

790

3056

P16

ICPC

Acute alcohol abuse

3.5

132.5

461

1317

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

132.2

1681

8882

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.6

132.0

766

2931

K51.8

ICD-10 Finland

Other ulcerative colitis

3.8

131.5

405

1065

K55.2

ICD-10 Finland

Angiodysplasia of colon

5.3

130.5

266

505

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

130.0

1951

10876

N06AX21

ATC

duloxetine; oral

1.7

129.9

2589

15675

A07EA02

ATC

hydrocortisone; rectal

3.0

129.4

585

1960

E87.6

ICD-10 Finland

Hypokalaemia

2.4

129.1

933

3958

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

129.1

7039

53243

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

128.6

2300

13508

D64.8

ICD-10 Finland

Other specified anaemias

3.0

128.6

589

1988

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.7

128.1

421

1158

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

128.0

4277

29356

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

4.2

126.7

344

826

D16

ICPC

Rectal bleeding

2.7

126.4

694

2582

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

126.2

1025

4573

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.1

126.0

1261

6115

A46

ICD-10 Finland

Erysipelas

1.6

125.7

3681

24521

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

125.6

3172

20404

UJK02

NOMESCO Finland

ERCP

2.6

125.0

755

2946

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

124.4

731

2814

D01

ICPC

Abdominal pain/cramps general

1.7

124.3

2804

17531

L28

ICPC

Limited function/disability (L)

1.5

123.6

4731

33384

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.0

123.3

358

903

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

122.9

4483

31318

3AC01, ,

NOMESCO Finland

4.3

122.5

320

746

WX872

NOMESCO Finland

Intensive care

2.1

122.2

1299

6441

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

121.3

1791

9925

D11

ICPC

Diarrhoea

1.7

120.4

2626

16265

K29.8

ICD-10 Finland

Duodenitis

4.4

120.0

303

688

Z93.2

ICD-10 Finland

Ileostomy status

7.5

119.5

171

227

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.5

118.6

413

1180

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.8

118.1

265

547

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

117.6

2338

14125

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

117.4

5525

40544

R10.0

ICD-10 Finland

Acute abdomen

2.4

117.3

841

3554

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

117.1

5891

43763

JAH01

NOMESCO Finland

Laparoscopy

2.2

116.7

1015

4656

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

7.0

116.6

179

257

M54.5

ICD-10 Finland

Low back pain

1.4

116.6

7968

62421

E0000UV, ,

ATC

1.4

116.5

9425

75877

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

116.5

604

2181

N06AX16

ATC

venlafaxine; oral

1.6

115.6

2840

18120

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

115.3

720

2854

WVA20

NOMESCO Finland

Medicine administration

2.5

115.3

764

3115

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.5

115.0

285

638

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

114.2

9114

73149

JDH25

NOMESCO Finland

Other endoscopic haemostatic procedure in duodenum

21.7

114.1

UJG02

NOMESCO Finland

Proctoscopy

2.7

114.1

615

2266

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.7

114.0

646

2442

K56.7

ICD-10 Finland

Ileus, unspecified

3.0

113.1

523

1774

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.9

113.0

539

1860

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.2

113.0

236

458

Z93.3

ICD-10 Finland

Colostomy status

4.4

112.5

283

641

M79.6

ICD-10 Finland

Pain in limb

1.4

112.4

9722

78952

C01DA14

ATC

isosorbide mononitrate; oral

1.5

112.3

4243

29791

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

112.2

6211

46876

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.4

112.0

283

643

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

111.9

1632

9001

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

111.7

5876

43942

WZC30

NOMESCO Finland

Teaching

1.5

111.0

3714

25418

K30

ICD-10 Finland

Functional dyspepsia

1.7

110.8

2478

15430

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

110.6

1012

4737

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.3

110.3

846

3681

UKC02

NOMESCO Finland

Cystoscopy

1.5

110.1

4051

28276

Z2221

NOMESCO Finland

Medical doctor

1.4

110.1

5965

44822

K86.3

ICD-10 Finland

Pseudocyst of pancreas

6.0

110.1

196

328

J04BA02

ATC

dapsone; oral

5.9

110.1

199

338

WX882

NOMESCO Finland

High dependency care

2.4

110.1

775

3248

K90

ICD-10 Finland

Intestinal malabsorption

46.2

109.8

S97

ICPC

Chronic ulcer skin

1.8

109.6

1645

9153

R03AC02

ATC

salbutamol; inhalant

1.3

109.2

12129

102133

A12AA04

ATC

calcium carbonate; oral

3.1

109.1

461

1485

R42

ICD-10 Finland

Dizziness and giddiness

1.4

108.9

5539

41141

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.9

108.9

324

832

J01DA01

ATC

[U] cefalexin

1.3

108.8

13893

119388

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

108.7

1570

8632

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

108.0

1352

7093

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

108.0

1221

6184

H04AA01

ATC

glucagon; nasal, parenteral

2.8

107.8

542

1925

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

107.6

4336

30810

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

107.1

2661

17004

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

7.5

107.0

153

203

K83.0

ICD-10 Finland

Cholangitis

3.2

106.7

439

1392

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

106.7

1790

10297

N05AA02

ATC

levomepromazine; systemic

2.2

106.6

922

4219

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.1

106.5

299

736

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

106.0

1065

5166

Z51.5

ICD-10 Finland

Palliative care

1.7

105.5

2261

13917

R13

ICD-10 Finland

Dysphagia

1.8

105.3

1691

9602

JFF13

NOMESCO Finland

Terminal enterostomy

8.4

105.0

137

163

R4110

NOMESCO Finland

Physiotherapy

1.4

104.5

6213

47367

R60.0

ICD-10 Finland

Localized oedema

1.6

104.3

3043

20183

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

104.3

3792

26374

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

103.8

1258

6527

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

103.2

1641

9289

A10AB01

ATC

insulin (human); parenteral

2.3

103.0

806

3537

S18

ICPC

Laceration/cut

1.3

102.2

10796

89907

N05CD07

ATC

temazepam; oral

1.6

101.7

2837

18619

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.9

101.6

1419

7715

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.6

101.5

585

2230

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.4

101.0

686

2828

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.2

100.7

409

1287

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

100.5

9266

75594

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.7

100.4

548

2032

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.8

100.2

514

1845

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

100.2

8574

69166

A10AB04

ATC

insulin lispro; parenteral

2.4

99.8

707

2971

A01

ICPC

Pain general/multiple sites

1.6

99.5

2337

14712

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

99.2

8297

66676

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

98.5

941

4476

127

Kela drug reimbursment

Transplant complication

3.1

98.3

412

1321

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

98.0

4213

30249

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

98.0

941

4485

N30.0

ICD-10 Finland

Acute cystitis

1.5

98.0

3817

26888

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

97.8

1015

4981

N06AB10

ATC

escitalopram; oral

1.5

97.8

4085

29170

Z94.4

ICD-10 Finland

Liver transplant status

7.2

97.6

145

201

B01AC04

ATC

clopidogrel; oral

1.5

97.2

4043

28841

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

97.0

11397

96103

JJC00

NOMESCO Finland

Allogenic transplantation of liver

9.5

97.0

115

121

K65.0

ICD-10 Finland

Acute peritonitis

3.4

96.9

354

1044

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

8.1

96.6

129

158

JDA35

NOMESCO Finland

Endoscopic contact coagulation in stomach or pylorus

11.6

96.1

C08CA01

ATC

amlodipine; oral

1.3

95.8

9045

73889

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

95.7

15963

141219

L04AA06

ATC

mycophenolic acid; systemic

2.8

95.6

482

1714

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

95.3

2646

17330

M10.9

ICD-10 Finland

Gout, unspecified

1.7

94.6

1769

10484

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

94.6

5999

46090

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

94.6

1056

5322

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

94.3

6092

46941

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

94.2

925

4446

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

93.9

4100

29498

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.6

93.9

573

2246

N19

ICD-10 Finland

Unspecified kidney failure

2.0

93.7

1007

5006

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

92.9

1011

5047

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

5.3

92.9

188

355

K85

ICD-10 Finland

Acute pancreatitis

2.9

92.7

449

1563

S06.0

ICD-10 Finland

Concussion

1.6

92.3

2466

15999

SPAT1260

SPAT

Consultation of another employee

1.5

92.1

3899

27877

UJH02

NOMESCO Finland

Anoscopy

2.1

91.7

917

4438

A07AA09

ATC

vancomycin; oral

3.0

91.5

415

1393

R55

ICD-10 Finland

Syncope and collapse

1.5

91.4

2748

18314

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

91.2

6176

47903

R04.0

ICD-10 Finland

Epistaxis

1.7

90.9

1872

11383

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

90.3

2162

13659

K91.9

ICD-10 Finland

Postprocedural disorder of digestive system, unspecified

229.0

89.2

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

89.1

4088

29655

I86.4

ICD-10 Finland

Gastric varices

17.9

88.9

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.5

88.8

313

902

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.5

88.4

313

905

K91.0

ICD-10 Finland

Vomiting following gastrointestinal surgery

226.5

88.2

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.5

87.8

546

2160

E87.5

ICD-10 Finland

Hyperkalaemia

2.6

87.5

540

2128

SPAT1240

SPAT

Therapeutic discussion

1.6

87.3

1966

12228

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

4.0

87.2

249

621

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

2.8

87.2

456

1654

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

87.1

361

1150

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

87.0

3553

25202

R33

ICD-10 Finland

Retention of urine

1.6

86.8

2099

13288

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

86.7

758

3482

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

86.6

956

4797

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.7

85.9

463

1706

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

5.0

85.7

187

377

130

Kela drug reimbursment

Malignant tumour

1.6

85.6

2081

13188

WX704

NOMESCO Finland

Intubation

1.7

85.6

1774

10799

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

3.7

85.4

268

715

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.8

85.3

195

409

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

84.7

1697

10237

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

84.3

1352

7662

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

84.1

14466

127312

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

8.6

83.8

107

124

V03AE01

ATC

polystyrene sulfonate; oral

3.0

83.3

381

1285

26900

ICD-8 Finland

Other nutritional deficiency, Sprue and steatorrhoea

30.4

83.2

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.5

82.7

549

2239

R02

ICPC

Shortness of breath/dyspnoea

1.5

82.6

3133

21888

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.2

82.5

221

526

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

82.4

1898

11868

N05AH03

ATC

olanzapine; systemic

1.8

82.3

1279

7178

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.9

82.2

1053

5560

207

Kela drug reimbursment

Chronic arrhythmias

1.4

82.2

3910

28506

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

82.2

1026

5371

W19

ICD-10 Finland

Unspecified fall

1.6

82.0

2322

15245

N17.8

ICD-10 Finland

Other acute renal failure

3.0

82.0

362

1197

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.4

81.9

557

2297

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

81.7

1120

6045

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

3.8

81.1

249

654

A10AA01, ,

ATC

2.4

80.6

553

2290

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

80.4

651

2897

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

80.4

1090

5863

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

80.2

662

2970

C05AA08

ATC

fluocortolone; rectal, topical

1.5

79.9

2825

19447

N18.0

ICD-10 Finland

End-stage renal disease

3.2

79.7

313

966

Z72.1

ICD-10 Finland

Alcohol use

3.2

79.5

322

1012

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

79.4

1230

6896

JF1AD

NOMESCO Finland

Small bowel CT

4.1

79.3

222

546

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.8

79.0

402

1437

5798A

ICD-9 Finland

Intestinal malabsorption, Other specified intestinal malabsorption[RUOKA-AINEALLERGIAAN LIITTYVÄ MALABSORPTIO]

+∞

79.0

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

78.8

1804

11257

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

3.3

78.7

297

894

K56.0

ICD-10 Finland

Paralytic ileus

3.4

78.7

287

846

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

78.5

1673

10253

E000001, ,

ATC

1.4

78.2

4121

30558

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

78.2

9032

75250

H02AB07

ATC

prednisone; oral

1.5

78.0

2935

20455

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.0

77.9

817

4022

D18

ICPC

Change in faeces/bowel movements

2.2

77.6

641

2876

C07AB02

ATC

metoprolol; systemic

1.4

77.4

4753

36145

OAB50, ,

SPAT

1.6

76.7

1810

11377

JDH15

NOMESCO Finland

Endoscopic injection in duodenum

23.8

76.5

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

76.2

353

1199

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

76.2

1720

10691

R03BB04

ATC

tiotropium bromide; inhalant

1.5

76.1

2360

15796

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.9

75.9

168

343

R31

ICD-10 Finland

Unspecified haematuria

1.5

75.7

2536

17255

N06AB03

ATC

fluoxetine; oral

1.5

75.6

2403

16169

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

4.6

75.5

179

387

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

9.5

75.4

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

75.4

2306

15387

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

75.3

2436

16451

A10AE06

ATC

insulin degludec; parenteral

2.1

75.2

759

3685

T90

ICPC

Diabetes non-insulin dependent

1.3

75.1

5436

42375

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.4

75.0

511

2109

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.6

75.0

247

681

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.8

74.8

170

355

L04AD02

ATC

tacrolimus; systemic

3.4

74.8

269

786

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

74.7

2156

14201

H02AB09

ATC

hydrocortisone; systemic

2.4

74.6

540

2290

A41.8

ICD-10 Finland

Other specified sepsis

2.4

74.2

506

2089

N06AA09

ATC

amitriptyline; systemic

1.6

74.0

1956

12627

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

74.0

5756

45336

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.0

73.9

209

518

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

7.1

73.8

111

156

J02AC01

ATC

fluconazole; systemic

1.3

73.8

7392

60316

A05AA02

ATC

ursodeoxycholic acid; oral

2.8

73.7

374

1335

C07AG02

ATC

carvedilol; oral

1.7

73.6

1373

8115

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

73.6

2548

17449

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

6.3

73.5

124

197

R04.2

ICD-10 Finland

Haemoptysis

2.0

73.2

841

4277

N05BA02

ATC

chlordiazepoxide; systemic

2.4

73.1

532

2262

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.6

73.1

423

1616

N03AX09

ATC

lamotrigine; oral

1.9

73.0

899

4683

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

5.6

72.8

137

242

J01MA14

ATC

moxifloxacin; systemic

1.6

72.7

1910

12311

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

72.5

3637

26704

D07AC01

ATC

betamethasone; topical

1.3

72.4

7870

64870

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

72.3

1420

8510

JFF10

NOMESCO Finland

Loop enterostomy

4.3

72.1

185

426

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

72.1

1087

6042

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

2.6

71.9

424

1635

R07.3

ICD-10 Finland

Other chest pain

1.5

71.9

2249

15074

AN1

Coronary angiography

1.5

71.8

2585

17839

K29.1

ICD-10 Finland

Other acute gastritis

2.9

71.8

334

1138

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.6

71.7

423

1631

D14

ICPC

Haematemesis/vomiting blood

8.9

71.1

JFF23

NOMESCO Finland

Transversostomy

3.1

70.9

302

978

C09AA05

ATC

ramipril; oral

1.3

70.7

5770

45712

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.2

70.7

277

854

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.0

70.6

754

3737

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.0

70.6

787

3961

B02AA02

ATC

tranexamic acid; systemic

1.5

70.6

2591

17946

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

70.5

1088

6088

K59.0

ICD-10 Finland

Constipation

1.7

70.5

1354

8065

SPAT1229

SPAT

Assessment of need for aid

1.6

70.2

1739

11052

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

70.1

1165

6664

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

12.8

70.1

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

69.9

2727

19112

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

2.2

69.8

578

2596

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

14.7

69.2

J01CA04

ATC

amoxicillin; systemic

1.3

69.2

18618

171047

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

68.9

1521

9395

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

2.6

68.7

406

1567

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.7

68.7

215

573

A07DA03

ATC

loperamide; oral

2.0

68.6

774

3912

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

68.5

4789

37061

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.6

68.4

231

648

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

68.4

1527

9460

N06AB06

ATC

sertraline; oral

1.5

68.4

2165

14541

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.3

68.3

254

758

SPAT1310

SPAT

Counselling related to known health issue

1.3

68.2

6684

54251

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

68.2

930

5008

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

3.2

68.1

273

853

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

4.1

67.8

187

455

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

67.8

1006

5562

SPAT1153

SPAT

Removal of sutures

1.3

67.8

6664

54103

205

Kela drug reimbursment

Chronic hypertension

1.3

67.8

6318

50930

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

3.3

67.8

252

752

H02AB04

ATC

methylprednisolone; systemic

1.4

67.6

2964

21225

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

67.5

1657

10505

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

67.4

966

5285

N05CF02

ATC

zolpidem; oral

1.4

67.3

3346

24499

K86.8

ICD-10 Finland

Other specified diseases of pancreas

5.1

67.0

141

276

SPAT1265

SPAT

Breathalyser

3.6

66.9

223

620

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

66.9

1810

11739

X58

ICD-10 Finland

Exposure to other specified factors

1.4

66.7

3005

21620

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

66.6

1411

8623

A03FA02

ATC

cisapride; oral, rectal

1.6

66.5

1641

10417

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

66.4

631

2994

SPAT1216

SPAT

Assessment of functional ability

1.4

66.3

3538

26214

G44.2

ICD-10 Finland

Tension-type headache

1.5

66.2

2629

18475

D94

ICPC

Chronic enteritis/ulcerative colitis

3.8

66.1

203

534

D07AA02

ATC

hydrocortisone; topical

1.4

65.9

2842

20284

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.3

65.8

171

398

JFB30

NOMESCO Finland

Right hemicolectomy

2.7

65.6

364

1362

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.5

65.6

402

1580

K22.7

ICD-10 Finland

Barrett oesophagus

2.8

65.5

334

1196

I81

ICD-10 Finland

Portal vein thrombosis

5.1

65.5

139

274

EBA00

NOMESCO Finland

Extraction of tooth

1.3

65.4

7719

64090

JFH10

NOMESCO Finland

Total colectomy and ileostomy

6.6

65.2

104

156

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

65.0

1845

12094

1370

FHL

Colonoscopy, whole colon

4.4

65.0

162

365

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.3

64.9

241

719

L04AD01

ATC

ciclosporin; systemic

2.5

64.6

402

1591

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

16.8

64.5

A07AA02

ATC

nystatin; oral

1.7

64.3

1262

7557

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.8

64.1

335

1215

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

64.0

1287

7757

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

63.8

1025

5804

N03AE01

ATC

clonazepam; systemic

1.7

63.8

1146

6701

N02BF02

ATC

pregabalin; oral

1.7

63.7

1375

8443

TJF80

NOMESCO Finland

Ostomy education

2.9

63.6

295

1004

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

63.3

1188

7030

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

3.3

63.2

238

716

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.9

63.1

300

1035

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

4.2

63.0

168

399

A04AA01

ATC

ondansetron; systemic, rectal

1.6

62.8

1686

10909

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.8

62.8

957

5333

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.4

62.8

231

685

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

62.7

537

2445

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.2

62.5

568

2649

SPAT1097

SPAT

Recording of ECG

1.4

62.4

3093

22611

SPAT1312

SPAT

General health counselling

1.3

62.4

6586

53846

WX725

NOMESCO Finland

Noninvasive ventilation

1.7

62.3

1159

6842

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.5

62.2

384

1514

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2.2

62.2

507

2263

K29.6

ICD-10 Finland

Other gastritis

2.9

62.2

294

1011

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

62.0

2969

21577

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

61.9

1913

12768

R52.9

ICD-10 Finland

Pain, unspecified

1.5

61.9

2168

14854

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

5.3

61.9

125

236

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

61.7

1725

11264

J01EA01

ATC

trimethoprim; systemic

1.3

61.5

5363

42741

ZY010

NOMESCO Finland

Hospital outpatient

1.8

61.5

979

5527

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

61.5

1260

7632

ZXA00

NOMESCO Finland

Right side

1.3

61.4

5585

44768

J01AA02

ATC

doxycycline; systemic

1.3

61.2

17406

159415

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

1.9

61.2

745

3864

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.1

61.1

597

2862

B01AF02

ATC

apixaban; oral

1.4

61.0

3127

22984

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.1

61.0

259

838

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

60.9

2969

21637

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

60.9

2595

18462

WX730

NOMESCO Finland

Conventional respirator

2.5

60.9

395

1595

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

2.7

60.9

329

1215

D02

ICPC

Abdominal pain epigastric

1.7

60.8

1265

7692

PD1CD

NOMESCO Finland

Very extensive CT of abdominal aorta and branches

5.3

60.7

123

233

Z71.8

ICD-10 Finland

Other specified counselling

1.3

60.4

7061

58429

L17

ICPC

Foot/toe symptom/complaint

1.3

60.3

6569

53874

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

60.3

913

5079

K83.1

ICD-10 Finland

Obstruction of bile duct

2.6

60.2

353

1358

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

60.2

4329

33563

L01BC06

ATC

capecitabine; oral

1.9

60.2

809

4336

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

60.1

1539

9848

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

3.2

60.1

241

754

JKA20

NOMESCO Finland

Cholecystectomy

2.0

60.0

623

3055

SPAT1139

SPAT

Nutrition survey

1.9

59.9

758

3982

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

59.9

1774

11732

N06AA12

ATC

doxepin; systemic

1.7

59.9

1060

6171

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

59.8

1180

7075

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

59.6

1252

7630

Z00.0

ICD-10 Finland

General medical examination

1.3

59.3

4125

31816

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

59.3

904

5039

SPAT1104

SPAT

Monitoring of emergency patient

1.6

59.2

1380

8632

D50

ICD-10 Finland

Iron deficiency anaemia

2.2

59.2

502

2277

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

59.0

2832

20573

K72.1

ICD-10 Finland

Chronic hepatic failure

8.0

58.9

100

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.8

58.7

179

469

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.6

58.6

195

542

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

58.6

1698

11174

A10AA02, ,

ATC

1.9

58.5

701

3616

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.4

58.4

427

1820

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.3

58.4

438

1888

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

5.6

58.3

110

195

Z94.0

ICD-10 Finland

Kidney transplant status

2.9

58.3

268

908

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

3.7

58.2

184

494

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

3.4

58.0

213

631

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

58.0

9345

80171

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

4.2

57.9

153

361

D06

ICPC

Abdominal pain localized other

1.5

57.8

1818

12175

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.6

57.8

331

1259

A02BA03

ATC

famotidine; systemic

1.8

57.7

843

4637

R06AE07

ATC

cetirizine; oral

1.2

57.6

8888

75865

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.7

57.5

1215

7414

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

57.5

1079

6382

M05BA04

ATC

alendronic acid; oral

1.5

57.3

1843

12399

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

57.2

2097

14490

A29

ICPC

General symptom/complaint other

1.4

57.0

2954

21734

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

56.8

1025

5997

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

56.8

458

2036

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

2.5

56.7

369

1492

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

56.5

4115

31926

V03AA01, ,

ATC

2.6

56.3

343

1345

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

56.1

6098

49915

JLC30

NOMESCO Finland

Pancreatoduodenectomy

3.9

56.0

168

435

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

55.9

1442

9241

69399

ICD-8 Finland

Dermatitis herpetiformis

12.1

55.9

H03AA01

ATC

levothyroxine sodium; systemic

1.3

55.7

4507

35485

26998

ICD-8 Finland

Other nutritional deficiency, Aliae definitae

9.3

55.6

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.4

55.6

395

1663

C09AA02

ATC

enalapril; systemic

1.3

55.5

4341

34012

S22.3

ICD-10 Finland

Fracture of rib

1.6

55.5

1561

10200

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

55.2

3516

26732

N06AX26

ATC

vortioxetine; oral

1.6

55.1

1410

9015

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.0

55.1

247

825

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

55.0

1414

9051

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

54.9

1215

7502

107

Kela drug reimbursment

Pernicious anaemia

2.2

54.8

465

2111

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.8

54.7

283

1022

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

54.6

7716

65103

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

54.6

676

3526

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

54.6

773

4211

N05BE01

ATC

buspirone; oral

2.0

54.4

576

2845

X57

ICD-10 Finland

Unspecified privation

2.1

54.4

505

2375

JN4CD

NOMESCO Finland

Very extensive body CT

1.8

54.2

775

4235

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

54.2

932

5380

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

54.0

524

2506

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

54.0

2438

17506

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

54.0

802

4435

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

53.9

3736

28754

K51

ICD-10 Finland

Ulcerative colitis

3.2

53.9

220

696

M05BX04

ATC

denosumab; parenteral

1.6

53.8

1304

8231

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

53.8

4510

35659

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

53.6

739

3993

S01.0

ICD-10 Finland

Open wound of scalp

1.5

53.5

1780

12054

N06AX03

ATC

mianserin; oral

1.7

53.5

952

5549

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.1

53.3

220

701

XF404

NOMESCO Finland

Ambulatory ECG

1.5

53.2

1827

12452

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.6

53.1

301

1139

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.7

53.0

170

461

N02BF01

ATC

gabapentin; oral

1.5

53.0

2042

14238

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

52.8

7773

65825

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

52.5

1417

9172

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

2.4

52.4

378

1602

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

52.3

2250

16010

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

2.0

52.2

609

3113

L01BB02

ATC

mercaptopurine; oral

2.9

52.2

253

883

N06AX12

ATC

bupropion; oral

1.6

52.1

1198

7466

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

52.1

859

4899

N05BA12

ATC

alprazolam; oral

1.5

52.0

1859

12772

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.0

51.9

237

800

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.5

51.9

1823

12482

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

51.8

1391

8991

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

51.7

1879

12949

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.0

51.7

567

2837

E87.2

ICD-10 Finland

Acidosis

3.7

51.7

164

442

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

51.6

1507

9925

A01AB09

ATC

miconazole; local oral

1.5

51.6

1735

11774

R15

ICD-10 Finland

Faecal incontinence

2.0

51.6

592

3010

A02BC04

ATC

rabeprazole; oral

1.5

51.5

1620

10841

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

8.5

51.4

K76.7

ICD-10 Finland

Hepatorenal syndrome

6.8

51.4

117

N05AF03

ATC

chlorprothixene; systemic

2.1

51.3

484

2291

J01FA06

ATC

roxithromycin; oral

1.2

51.3

8016

68279

H3603, E103,

ICD-10 Finland

3.1

51.1

211

672

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

2.7

51.1

267

970

D97

ICPC

Liver disease NOS

3.9

51.0

149

379

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.5

50.9

336

1368

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.3

50.9

193

584

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

50.9

1056

6413

N03AG01

ATC

valproic acid; systemic, rectal

1.6

50.7

1140

7064

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

50.6

489

2336

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

50.6

2023

14201

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.1

50.4

490

2346

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

4.1

50.3

137

331

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

50.2

879

5098

A06AC51

ATC

ispaghula, combinations; oral

1.7

50.2

965

5743

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

3.7

50.0

161

438

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

3.5

50.0

176

508

I95.9

ICD-10 Finland

Hypotension, unspecified

2.3

49.9

376

1624

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

49.9

865

5004

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

49.8

2738

20313

P03

ICPC

Feeling depressed

1.5

49.7

1766

12115

XCK10

NOMESCO Finland

Photography of fundus of eye

1.4

49.4

1998

14053

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

49.0

628

3315

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

48.8

653

3494

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

4.3

48.8

124

284

D09

ICPC

Nausea

1.7

48.8

913

5394

A10BH01

ATC

sitagliptin; oral

1.4

48.8

1984

13966

N05AX12

ATC

aripiprazole; systemic

1.9

48.6

669

3612

R52.2

ICD-10 Finland

Other chronic pain

1.8

48.3

730

4058

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

48.2

1121

7003

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

48.0

588

3056

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.6

47.9

158

437

ZXA05

NOMESCO Finland

Left side

1.3

47.8

5095

41465

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

47.8

542

2745

WVA20, ,

SPAT

1.8

47.6

749

4213

B01AB04

ATC

dalteparin; parenteral

1.6

47.6

1066

6600

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

47.5

979

5933

K72.9

ICD-10 Finland

Hepatic failure, unspecified

3.7

47.5

150

403

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

5.2

47.5

189

J01CA08

ATC

pivmecillinam; oral

1.2

47.4

7588

64663

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.6

47.3

266

1003

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

47.3

7521

64042

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

47.3

1759

12172

G04CA02

ATC

tamsulosin; oral

1.3

47.2

5764

47663

V03AE02

ATC

sevelamer; oral

3.8

47.1

146

387

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

47.1

1374

9043

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

47.1

1611

10964

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.1

46.7

469

2273

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

46.7

195

626

A02BX02

ATC

sucralfate; oral

1.7

46.6

833

4860

R52.0

ICD-10 Finland

Acute pain

1.9

46.6

648

3511

TK810

NOMESCO Finland

Hemofiltration

3.4

46.5

165

479

PC4SC

NOMESCO Finland

Bowel angiography with X-ray

7.4

46.5

JAD10

NOMESCO Finland

Repair of incisional hernia

3.1

46.4

191

608

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

2.4

46.3

307

1254

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.5

46.1

1295

8452

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

6.1

46.1

131

M25.5

ICD-10 Finland

Pain in joint

1.2

46.1

6328

53001

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.2

46.0

408

1886

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.1

45.9

450

2161

A10BA02

ATC

metformin; oral

1.2

45.9

6195

51781

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

3.3

45.9

171

512

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

45.9

4292

34343

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

4.6

45.9

108

233

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

3.5

45.8

159

455

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.0

45.8

206

690

SPAT1252

SPAT

Overall medication plan or its review

1.5

45.8

1438

9614

A10BH05

ATC

linagliptin; oral

1.6

45.7

1146

7289

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

45.7

311

1285

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.7

45.7

961

5856

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

45.7

11199

99480

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

45.6

3997

31707

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

45.6

1561

10623

ZXA10

NOMESCO Finland

Bilateral

1.3

45.5

3825

30173

P76

ICPC

Depressive disorder

1.6

45.5

1139

7240

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.3

45.3

173

526

SPAT1125

SPAT

Stoma care and guidance

2.2

45.2

398

1835

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.7

45.1

248

925

K22.2

ICD-10 Finland

Oesophageal obstruction

2.7

45.1

235

853

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

44.9

549

2852

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.2

44.9

175

539

M01AB55

ATC

diclofenac, combinations; oral

1.5

44.7

1322

8724

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.4

44.7

113

258

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.0

44.5

468

2308

J01FA09

ATC

clarithromycin; systemic

1.2

44.4

5908

49268

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

5.9

44.4

136

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.4

44.4

308

1284

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.6

44.2

145

400

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

44.1

596

3199

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.2

44.1

369

1666

K28.9

ICD-10 Finland

Gastrojejunal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

6.4

44.1

114

R03BA05

ATC

fluticasone; inhalant

1.3

44.0

3526

27625

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

4.7

43.9

100

210

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

3.0

43.9

199

670

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

43.6

1874

13314

J01DA09

ATC

[U] cefadroxil

1.3

43.6

5106

41953

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

43.6

2446

18185

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.0

43.6

455

2238

SPAT1211

SPAT

Application of soft bandage

1.4

43.6

1780

12532

I20.09

ICD-10 Finland

Unstable angina

1.5

43.4

1273

8387

JJ5AT, ,

NOMESCO Finland

9.7

43.1

JAH33

NOMESCO Finland

Opening of laparostomy

6.6

43.1

104

XKD00

NOMESCO Finland

Uroflowmetry

1.3

43.0

3624

28576

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

4.6

42.9

101

218

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

42.8

756

4395

E83.51

ICD-10 Finland

Hypocalcemia

3.3

42.8

162

490

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.1

42.8

178

570

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12878

96703

1.65

319.73

3.3

2.4

76.19

1020.92

nmol/l

0.50

11739

86926

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

11310

82257

1.66

317.92

4.7

3.6

1.98

1.96

e6/l

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3250

16211

2.13

312.35

3.0

2.9

10.99

10.56

g/l

5.55

3010

14972

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5070

27318

2.05

307.65

10.0

7.3

5.00

5.08

kpa

6.69

4893

26215

(3014576) Chloride [Moles/volume] in Serum or Plasma

6005

31793

2.14

307.65

10.3

7.0

104.25

104.32

mmol/l

0.45

6000

31774

(3006504) Eosinophils/Leukocytes in Blood

13876

101729

1.78

307.65

8.7

6.5

2.81

2.84

0.83

13171

95108

(3023520) Reticulocytes [#/volume] in Blood

4446

21557

2.27

307.65

2.9

2.6

72.54

67.93

e9/l

11.27

3320

15882

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20199

163731

2.08

307.65

13.6

8.1

86.61

80.44

u/l

37.03

19549

155120

(3018010) Neutrophils/Leukocytes in Blood

13837

102108

1.75

307.65

8.5

6.4

58.84

57.76

21.33

13337

97304

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6565

39809

1.86

307.65

2.4

1.9

—

(3027945) Reticulocytes/Erythrocytes in Blood

5604

27901

2.27

307.65

2.9

2.5

1.96

1.74

32.80

5074

24642

(3018418) pH of Serum or Plasma

9803

67714

1.71

307.65

6.3

4.2

7.40

1.75

7564

48335

(3013115) Eosinophils [#/volume] in Blood

15239

113694

1.82

307.65

8.7

6.5

0.19

0.20

e9/l

0.91

13563

98344

(3024561) Albumin [Mass/volume] in Serum or Plasma

15107

100553

2.21

307.65

8.5

4.9

34.15

35.38

g/l

116.55

14395

93772

(3021960) Folate [Moles/volume] in Serum or Plasma

9832

65269

1.81

307.65

2.1

1.7

20.00

19.92

nmol/l

0.20

8703

55291

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

14166

101512

1.87

307.65

10.9

6.6

1.20

1.21

mmol/l

50.39

13325

93627

(3007164) IgA [Mass/volume] in Serum or Plasma

7139

40584

2.04

307.65

1.7

1.5

2.70

2.45

g/l

13.75

4532

24514

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4147

16521

2.78

307.65

2.1

1.6

—

(3022096) Basophils/Leukocytes in Blood

13839

101743

1.77

307.65

8.9

6.6

0.65

0.66

1.38

13136

95081

(3003458) Phosphate [Moles/volume] in Serum or Plasma

6046

30443

2.27

307.65

8.7

5.8

1.06

1.04

mmol/l

5.38

5739

28195

(3023183) Ammonium ion [Moles/volume] in Plasma

1637

4638

3.67

307.65

4.5

2.2

38.05

32.16

umol/l

12.97

1515

4109

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4311

22428

2.09

307.65

10.8

8.0

114.35

121.70

g/l

91.15

4240

21891

(3020779) Urea [Moles/volume] in Serum or Plasma

4473

21161

2.33

307.65

10.5

7.0

11.09

10.37

mmol/l

7.22

4278

20108

(3022948) Iron [Moles/volume] in Serum or Plasma

8097

39731

2.50

307.65

3.6

2.6

11.48

12.80

umol/l

42.82

7621

36769

(3012544) pH of Venous blood

4806

24444

2.17

307.65

6.3

4.0

7.37

7.38

3.99

2998

14230

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5909

34877

1.89

307.65

2.9

2.1

30.37

29.74

10.06

5738

33927

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7675

37071

2.51

307.65

3.6

2.5

2.32

2.30

g/l

2.27

7160

34083

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4995

25006

2.22

307.65

4.3

2.7

10.93

9.02

umol/l

4.20

4409

21849

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13376

99418

1.71

307.65

2.6

2.2

93.91

95.19

pmol/l

2.30

7851

53501

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12241

68866

2.47

307.65

4.1

2.6

64.64

63.19

u/l

0.11

11649

63578

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

15611

113244

1.95

307.65

11.7

7.1

1.20

1.21

mmol/l

58.25

13699

97442

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

16899

114613

2.38

307.65

10.1

6.4

12.27

11.99

umol/l

1.20

16324

108965

(3013650) Neutrophils [#/volume] in Blood by Automated count

16430

123098

1.91

307.65

12.5

9.5

4.37

4.23

e9/l

8.77

14714

105865

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4348

23059

2.05

307.65

4.5

4.1

19.10

26.66

ug/l

1.04

3659

18930

(3003396) Base excess in Arterial blood by calculation

5055

27136

2.06

307.65

9.9

7.2

0.89

0.91

mmol/l

0.11

4166

22319

(40768797) Stomach Pathology biopsy report

6866

28000

2.96

307.65

1.5

1.2

—

(3016502) Oxygen saturation in Arterial blood

4694

24296

2.12

307.65

10.2

7.6

95.52

95.43

0.40

4556

23421

(3002030) Lymphocytes/Leukocytes in Blood

14044

104237

1.75

307.65

8.8

6.5

25.61

27.18

51.16

13464

98554

(3001604) Monocytes [#/volume] in Blood

14889

110201

1.82

307.65

8.4

6.3

0.61

0.60

e9/l

6.31

13127

93808

(3024354) Oxygen [Partial pressure] in Venous blood

3945

20212

2.11

307.65

5.4

3.4

4.51

kpa

0.02

3836

19656

(3019977) pH of Arterial blood

5106

27269

2.07

307.65

10.0

7.3

7.42

0.65

2919

14835

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8293

46160

2.16

307.65

1.8

1.3

7.26

1.18

u/ml

76.75

2768

11860

(3006315) Basophils [#/volume] in Blood

14927

110547

1.82

307.65

8.4

6.3

0.04

e9/l

1.26

13176

94116

(3023368) Bacteria identified in Blood by Culture

10370

65415

1.97

307.65

6.3

4.3

—

(3019069) Monocytes/Leukocytes in Blood

13935

101992

1.79

307.65

8.8

6.6

9.08

8.94

6.53

13233

95367

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2614

11091

2.49

307.65

1.8

1.7

1.48

1.55

g/l

3.44

2274

9469

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4765

24101

2.18

307.65

6.3

3.9

5.77

5.82

kpa

2.83

4643

23508

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10580

70095

1.85

307.65

4.9

3.2

36.88

34.33

u/l

1.41

10004

65910

(3022145) Colonoscopy Study observation

4885

23789

2.28

307.65

1.5

1.4

—

(3000991) Gas panel - Venous blood

4008

20680

2.10

307.65

12.3

8.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8570

53946

1.87

307.65

3.8

2.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3937

20548

2.07

307.65

3.9

2.4

44.97

46.23

u/l

0.08

3411

17322

(3019198) Lymphocytes [#/volume] in Blood

15100

112698

1.81

307.65

8.5

6.3

1.78

1.91

e9/l

10.77

13573

98266

(3002032) Base excess in Venous blood by calculation

4607

23540

2.15

307.65

6.3

4.0

1.44

1.78

mmol/l

6.87

4021

20575

(3001122) Ferritin [Mass/volume] in Serum or Plasma

14645

100351

2.05

307.65

4.7

3.1

127.28

135.38

ug/l

2.80

13744

92971

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2083

6300

3.48

307.65

1.7

1.4

219.19

275.45

ug/g

23.48

1279

3694

(3032080) INR in Blood by Coagulation assay

15467

105223

2.17

307.65

21.6

16.5

1.31

1.30

inr

0.44

13557

88122

(3027801) Oxygen [Partial pressure] in Arterial blood

5065

27304

2.05

307.65

10.0

7.3

11.98

12.27

kpa

3.82

4888

26188

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4762

21133

2.52

307.65

3.4

2.2

0.20

0.21

g/l

21.73

4413

19621

(3048689) Calprotectin [Mass/mass] in Stool

5110

25893

2.20

307.65

3.3

2.4

181.68

138.76

ug/g

9.51

4218

20391

(3019309) Folate [Moles/volume] in Red Blood Cells

6869

40385

1.94

307.65

2.0

1.8

1210.93

1148.55

nmol/l

5.77

5416

30352

(3014111) Lactate [Moles/volume] in Serum or Plasma

4154

21177

2.13

307.65

9.8

7.3

1.47

1.35

mmol/l

6.03

4073

20711

(3013826) Glucose [Moles/volume] in Serum or Plasma

16989

130040

1.89

307.65

8.7

5.1

6.95

6.75

mmol/l

22.74

16434

123321

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14205

100539

1.91

307.65

4.2

2.8

—

estimate

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11191

60194

2.51

307.65

3.4

2.3

3.18

2.83

mg/l

32.94

10040

51663

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6977

37292

2.18

307.65

4.9

3.4

0.80

0.82

mmol/l

32.05

6597

34881

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7178

34305

2.50

307.65

3.7

2.6

20.22

22.38

28.15

6763

31680

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5100

27533

2.05

307.65

4.2

4.3

240.42

246.19

u/l

1.95

4840

26041

(3020961) Endomysium IgA Ab [Titer] in Serum

2444

9062

2.85

307.65

1.4

1.1

193.67

190.48

titre

0.03

365

128

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

11704

85309

1.67

307.65

5.6

4.0

54.12

80.21

ng/l

1.74

9036

62039

(3031040) Bacteria [#/volume] in Urine by Automated count

17564

143640

1.69

304.55

6.7

4.9

1289.22

1731.76

e6/l

0.67

299

2211

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1801

7042

2.65

301.00

1.5

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2885

13997

2.18

296.72

6.7

4.1

23.80

24.17

mmol/l

7.30

2848

13804

(3042936) Bacteria identified in Isolate by Culture

5337

32072

1.82

296.21

2.7

2.0

—

(3033658) Prothrombin time (PT) actual/Normal

8228

55923

1.68

294.72

7.8

4.1

83.97

87.37

26.86

8055

54731

(3000850) Epithelial cells [#/volume] in Urine

7756

51923

1.69

294.05

3.6

2.8

5.37

5.18

e6/l

0.67

7212

47193

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

5001

29632

1.84

289.83

2.2

1.8

—

(3026782) Osmolality of Urine

6838

44480

1.72

287.01

3.9

3.0

509.95

539.63

mosm/kgh2o

26.41

6175

38987

(3002582) Erythrocytes [#/volume] in Urine

10341

75055

1.62

282.17

4.7

3.5

79.84

96.81

e6/l

0.58

8497

57414

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4704

27723

1.84

275.80

2.3

1.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

2635

12683

2.18

275.38

1.8

2.0

1.29

1.34

g/l

0.68

2432

11619

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9811

70793

1.61

271.02

4.0

3.3

2156.24

1583.20

ng/l

13.91

8645

61235

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3660

20009

1.95

270.12

2.4

2.3

379.77

380.92

nmol/l

0.10

3427

18485

(3004119) Hemoglobin [Mass/volume] in Venous blood

2875

14470

2.09

267.26

5.0

3.4

119.79

129.52

g/l

80.58

2790

14068

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1608

6363

2.61

261.36

3.4

2.6

3.35

3.60

g/l

8.67

1533

6090

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6964

46530

1.67

259.43

2.0

1.7

16192389.58

28443874.03

pmol/l

1.70

5898

38174

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

9619

69674

1.59

257.78

2.7

2.2

213.00

218.80

u/l

0.23

9191

65684

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

18494

156001

1.64

256.03

5.9

4.4

15.27

12.60

mm/h

81.28

17420

145335

(3014007) Fractional oxyhemoglobin in Arterial blood

2956

15292

2.04

254.32

12.4

9.3

93.57

93.87

1.45

2941

15245

(3037467) Urinalysis macro (dipstick) panel - Urine

17690

147877

1.61

251.11

6.4

4.7

1.93

2.38

0.51

219

(3007566) Smooth muscle Ab [Titer] in Serum

1462

5641

2.67

249.78

1.4

1.2

116.38

122.31

titre

0.10

152

536

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2854

14847

2.02

240.98

12.6

9.4

0.65

0.63

0.80

2829

14762

(3030467) Casts [#/volume] in Urine by Automated count

9007

65023

1.58

240.22

4.6

3.4

0.50

0.44

e6/l

1.08

7227

47917

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1790

7759

2.39

238.73

4.1

3.1

0.30

0.36

iu/ml

9.16

1022

4250

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2912

15330

2.00

237.57

12.4

9.1

1.39

1.31

4.83

2888

15233

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2607

13215

2.07

236.14

12.7

9.4

15.10

16.11

58.85

2547

12738

(3034770) Mitochondria Ab [Titer] in Serum

1425

5584

2.62

235.71

1.3

1.2

718.93

931.04

titre

0.62

163

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2472

12318

2.10

234.34

4.5

3.0

1.32

1.21

5.76

2462

12265

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2758

14385

2.01

230.59

9.4

6.5

24.18

24.51

mmol/l

3.91

2671

13756

(3015377) Calcium [Moles/volume] in Serum or Plasma

10202

76251

1.55

230.55

4.1

3.4

2.33

2.35

mmol/l

40.27

9289

68915

(3018095) Leukocytes [#/volume] in Urine

11092

84464

1.54

229.96

5.5

4.1

126.18

107.58

e6/l

1.04

8707

59897

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2945

15753

1.97

228.97

11.6

8.0

24.46

24.78

mmol/l

4.57

2927

15625

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6850

46757

1.62

228.93

2.4

1.7

1.40

1.35

mg/l

0.60

5473

36373

(3007853) Bacteria identified in Skin by Aerobe culture

4366

26454

1.77

228.58

2.2

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3897

22926

1.81

225.13

1.9

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2430

12208

2.08

224.94

4.5

2.9

0.65

0.62

4.97

2423

12167

(3037522) Nuclear Ab [Titer] in Serum

4615

28555

1.74

223.95

1.5

1.4

528.62

515.36

titre

0.19

1067

6149

(36304419) Bacteria [Presence] in Urine

8504

61456

1.56

221.03

4.4

3.4

1688.61

83.90

estimate

0.73

303

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1759

7947

2.28

212.44

3.8

3.4

1069.93

2055.20

u/ml

0.99

1544

6825

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

16351

136536

1.53

211.42

5.4

3.2

68.33

49.54

u/l

56.37

15485

127501

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

879

2832

3.15

208.50

3.1

2.9

1545.32

534.78

u/ml

0.46

861

2800

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1779

8201

2.24

204.45

2.2

1.7

0.41

0.30

mg/l

9.71

933

3805

(3020630) Protein [Mass/volume] in Serum or Plasma

3435

19978

1.82

204.43

2.5

2.7

65.48

66.22

g/l

5.97

3173

18182

(3013005) Retinol [Moles/volume] in Serum or Plasma

428

838

5.14

202.69

3.7

1.7

1.89

1.94

umol/l

0.46

403

776

(3025941) Bacteria identified in Stool by Culture

2194

11026

2.07

201.94

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1450

6157

2.42

201.63

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3065

17318

1.86

200.00

5.4

3.9

107.38

91.46

ng/l

11.23

2634

14854

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1979

9607

2.13

199.57

2.2

1.9

2.35

2.14

ug/l

0.31

1772

8430

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2619

14151

1.93

195.87

12.0

9.1

24.05

24.26

mmol/l

2.18

2550

13778

(36660697) Celiac disease serology panel - Serum

2929

16431

1.87

195.21

1.4

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

14161

116220

1.47

187.80

5.3

4.0

12.14

3.63

estimate

3.73

3512

24517

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

4663

30224

1.65

186.00

1.9

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1205

4881

2.52

185.28

1.3

1.1

18.41

4.24

eliau/ml

9.68

248

494

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6308

44034

1.56

184.14

5.4

4.1

380.10

471.31

ng/l

0.79

5121

35697

(3009261) Glucose [Presence] in Urine by Test strip

14209

116969

1.46

183.51

5.3

4.0

0.33

0.35

estimate

0.02

3280

23137

(3021601) Nitrite [Presence] in Urine by Test strip

13990

114835

1.46

183.32

5.2

4.0

0.00

estimate

0.05

3414

23958

(3027273) Bicarbonate [Moles/volume] in Venous blood

2092

10705

2.02

182.46

5.1

3.5

24.78

25.23

mmol/l

6.56

2027

10364

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

407

844

4.85

180.23

3.7

1.7

25.36

29.15

umol/l

9.56

391

793

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1281

5406

2.42

180.17

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

6569

46573

1.54

177.62

6.1

4.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2213

11778

1.95

172.01

6.1

4.0

47.14

47.13

0.01

2184

11614

(3021589) Normoblasts [#/volume] in Blood

11866

95214

1.44

169.97

19.4

11.6

0.00

e9/l

0.49

9905

77143

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2005

10364

2.00

169.48

6.8

4.7

1.69

1.60

2.80

1920

9819

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1977

10190

2.00

168.44

1.3

1.1

36.21

1.27

u/ml

2.47

(3020891) Body temperature

2049

10753

1.97

165.69

7.1

4.3

36.93

36.91

°c

2.59

2029

10642

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2794

16201

1.80

165.49

6.0

3.9

5.09

5.14

kpa

2.36

2681

15389

(3018405) Lactate [Moles/volume] in Arterial blood

1561

7423

2.16

165.04

5.5

3.9

1.53

1.39

mmol/l

3.50

1523

7276

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1717

8491

2.08

163.81

2.6

2.2

631.95

574.10

ug/l

0.18

1635

8033

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3676

23173

1.67

160.97

2.4

1.7

1.67

1.47

33.49

3131

20171

(3015736) pH of Urine

11582

93196

1.43

159.51

4.5

3.6

6.28

6.24

3.68

6665

50965

(3007930) Methemoglobin/Hemoglobin.total in Blood

1843

9473

2.00

157.90

7.1

4.9

0.88

0.87

0.78

1767

8949

(3009343) pH of Capillary blood

2708

15771

1.79

157.59

6.0

3.9

7.41

7.42

3.27

2378

13077

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2116

11414

1.92

157.40

2.6

2.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2456

13920

1.83

156.36

5.8

3.8

1.57

1.76

mmol/l

1.49

1777

10232

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1083

4538

2.43

154.36

6.4

5.6

807.26

1293.94

iu/ml

0.56

183

664

(3017181) Myelocytes/Leukocytes in Blood

3219

19819

1.70

153.50

5.1

4.3

0.95

0.94

0.09

1232

6131

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1379

6451

2.19

151.67

3.4

2.5

88.72

91.94

4.76

1329

6221

(3024928) Oxygen saturation in Venous blood

1272

5766

2.25

151.17

4.5

3.3

60.30

61.37

0.85

1217

5539

(40758558) Short blood count panel - Blood

8490

65004

1.44

151.12

9.0

6.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1087

4607

2.40

151.01

4.0

3.3

397.99

1058.54

u/ml

1.98

980

4175

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1525

7441

2.10

150.44

1.6

23.35

19.26

u/ml

0.95

271

1657

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

834

3136

2.69

148.87

7.0

6.2

12.34

11.89

mg/l

1.89

771

2876

(3026493) Urate [Moles/volume] in Serum or Plasma

7727

58260

1.45

148.72

3.4

2.8

358.98

349.08

umol/l

11.20

6806

50930

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3525

22462

1.65

146.81

4.9

3.5

—

(3002179) Metamyelocytes/Leukocytes in Blood

3054

18838

1.69

143.95

4.9

4.2

0.73

0.70

0.23

1167

5820

(3047181) Lactate [Moles/volume] in Blood

1385

6663

2.12

141.60

7.5

5.5

1.45

1.32

mmol/l

4.02

1239

5890

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

431

1135

3.82

139.70

3.4

2.2

95.12

97.64

0.65

414

1077

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1274

5964

2.18

139.64

3.9

2.5

206.92

194.24

4.60

1214

5671

(3024980) IgG subclass 4 [Mass/volume] in Serum

865

3424

2.56

139.10

1.9

1.6

0.79

0.80

g/l

0.11

663

2649

(3036489) Thrombin time

1560

7925

2.02

137.57

3.1

2.1

22.14

21.20

3.21

1393

7084

(1616796) Gas panel - Central venous blood

1152

5257

2.23

134.44

5.0

3.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1610

8340

1.98

134.23

4.1

3.0

24.36

24.71

mmol/l

2.61

1573

8192

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

671

2397

2.83

132.08

1.3

1.1

11.07

2.71

eliau/ml

8.60

253

1027

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3102

19630

1.65

131.63

2.9

2.4

6.51

7.36

ug/l

1.41

2707

16931

(3025159) Blasts/Leukocytes in Blood

3032

19082

1.65

131.46

5.4

4.5

0.10

0.36

4.31

991

5066

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1762

9486

1.91

130.95

1.5

1.6

13.97

14.06

iu/ml

0.01

230

(3021440) Promyelocytes/Leukocytes in Blood

3012

18984

1.65

129.72

5.3

4.3

0.11

0.10

1034

5334

(3026692) Albumin [Mass/volume] in Peritoneal fluid

272

530

5.14

129.55

1.7

1.3

10.72

14.50

g/l

8.78

196

405

(3029937) Albumin [Presence] in Urine by Test strip

8298

64598

1.41

129.33

5.4

4.2

0.00

estimate

0.30

3093

21739

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22215

204900

1.59

127.95

32.4

16.9

25.16

26.00

mg/l

3.62

20163

170730

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1574

8227

1.96

127.68

2.8

3.4

46.81

45.54

mg/l

0.14

1306

6972

(3034860) Kappa light chains.free [Mass/volume] in Serum

1575

8237

1.96

127.54

2.8

3.4

130.61

55.48

mg/l

0.95

1302

6982

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10610

86296

1.38

126.18

5.3

4.0

0.71

0.50

estimate

0.27

2857

19660

(3023487) Leukocytes [#/volume] in Peritoneal fluid

320

736

4.36

124.67

2.5

1.9

3349.35

2280.01

e6/l

0.19

236

490

(3028626) Oxygen [Partial pressure] in Capillary blood

1312

6551

2.04

121.03

6.5

3.7

8.21

8.26

kpa

0.45

1284

6385

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

17911

159204

1.39

117.92

5.1

4.3

14.89

14.85

pmol/l

1.21

16425

145307

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1295

6515

2.02

116.92

2.1

1.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5574

41032

1.45

116.26

3.9

3.1

1.21

1.19

e6/l

0.07

3226

22007

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5192

37730

1.46

115.91

4.1

3.2

2.99

2.52

e6/l

2.02

2814

18628

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2930

18860

1.61

114.94

3.9

3.1

264.55

227.85

ng/l

3.38

2703

17290

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1411

7360

1.95

114.84

2.7

3.3

5.43

4.52

ratio

0.20

792

4306

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6010

44955

1.43

114.58

3.6

3.0

2.46

mmol/l

0.58

5327

40109

(3021901) Oxygen saturation in Capillary blood

1068

5051

2.15

113.69

4.0

3.0

89.72

89.63

0.15

1042

4912

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

279

625

4.47

112.44

2.2

1.8

7406.82

14308.95

e6/l

0.78

164

319

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

703

2799

2.53

111.53

1.1

1.57

1.51

g/l

2.70

649

2544

(3019230) Fractional oxyhemoglobin in Venous blood

1028

4834

2.16

111.02

4.5

3.1

60.08

61.87

1.59

1022

4815

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1498

8072

1.89

110.48

1.3

—

(3003181) Sodium [Moles/volume] in Urine

940

4304

2.21

108.50

2.0

1.4

60.12

62.42

mmol/l

0.90

733

3475

(3044007) Cell count panel - Peritoneal fluid

272

617

4.41

107.91

2.2

1.8

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

4888

35553

1.45

107.45

2.2

1.9

—

(3010421) pH of Blood

1363

7192

1.93

107.06

5.7

3.5

7.41

1.60

1346

7077

(3043409) Potassium [Moles/volume] in Arterial blood

1224

6250

1.99

105.78

6.1

4.1

3.90

3.89

mmol/l

0.30

1208

6197

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1151

5766

2.03

104.95

2.8

2.2

123.24

129.45

g/l

12.59

933

4420

(3000012) Reticulocyte production index

791

3424

2.33

104.37

2.4

2.2

0.95

0.89

1.88

591

2325

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1308

6870

1.94

104.10

5.5

4.0

1.85

1.55

mg/l

20.24

1210

6240

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2753

17892

1.59

102.97

6.0

3.8

1.22

1.23

mmol/l

8.56

2474

15310

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1219

6283

1.97

102.50

1.8

1.7

0.23

g/l

2.49

1154

5990

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

811

3578

2.29

102.34

3.9

3.0

875.44

4299.22

u/ml

0.73

214

(3027315) Oxygen [Partial pressure] in Blood

1002

4825

2.10

101.64

6.1

3.9

8.60

8.52

kpa

0.60

982

4700

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1147

5806

2.01

101.54

1.7

1.6

—

(3012501) Base excess in Blood by calculation

995

4801

2.10

100.38

6.1

3.9

2.67

2.54

mmol/l

0.77

704

3224

(3013290) Carbon dioxide [Partial pressure] in Blood

995

4803

2.10

100.27

6.1

3.9

4.99

kpa

0.04

975

4679

(40767503) Oxygen content in Capillary blood by calculation

1006

4886

2.09

99.73

3.5

2.6

15.58

16.41

12.48

981

4785

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1233

6460

1.94

98.76

1.8

1.7

1.16

1.19

g/l

1.74

1176

6181

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1157

5940

1.98

98.33

1.8

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2411

15388

1.61

96.95

1.5

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

477

1675

2.86

96.90

2.0

1.4

1.40

1.18

promille

2.10

369

1314

(3002331) Protein [Mass/volume] in Peritoneal fluid

219

458

4.78

96.11

1.4

21.00

42.93

g/l

1.04

163

359

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

515

1894

2.73

95.86

1.5

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

9392

77297

1.33

93.93

4.1

3.5

7.10

7.56

mmol/l

20.11

8036

64974

(3000494) Fungus identified in Specimen by Culture

3677

25957

1.47

92.88

1.7

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

857

4030

2.15

92.38

1.5

1.3

279.12

260.88

u/ml

0.94

536

2480

(3022493) Free Hemoglobin [Mass/volume] in Plasma

325

936

3.48

92.29

5.1

3.6

690.34

766.69

mg/l

0.04

245

655

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

890

4263

2.11

91.46

1.7

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

7589

60816

1.34

90.29

4.8

3.5

0.34

0.26

estimate

0.22

2797

18868

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

880

4234

2.10

89.35

1.7

1.4

20.61

22.64

u/ml

0.16

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

892

4314

2.09

89.34

1.4

1.3

73.25

45.32

u/ml

0.32

(3014765) Yersinia sp identified in Stool by Organism specific culture

1078

5594

1.95

88.68

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

651

2782

2.36

88.41

1.6

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

1078

5610

1.95

87.93

1.3

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

272

719

3.78

87.78

3.4

2.6

0.60

0.61

mmol/l

2.86

272

719

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1648

9777

1.72

87.58

2.3

3.72

3.73

g/l

0.09

1518

8851

(3028271) Lactate [Moles/volume] in Capillary blood

772

3558

2.19

87.54

2.5

1.8

1.79

1.70

mmol/l

1.51

751

3467

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1068

5556

1.95

87.19

1.3

1.2

—

(3039000) Anion gap in Blood by calculation

926

4585

2.04

87.01

9.1

6.4

11.54

11.27

mmol/l

1.36

861

4106

(3018572) Chloride [Moles/volume] in Blood

926

4586

2.04

86.96

9.2

6.4

104.98

105.02

mmol/l

0.08

861

4108

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1650

9813

1.71

86.88

2.3

7.42

7.41

g/l

0.10

1519

8874

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1648

9800

1.71

86.81

2.3

4.20

g/l

0.07

1519

8872

(3017732) Neutrophils [#/volume] in Blood

3754

26960

1.45

86.05

3.4

3.2

4.89

4.66

e9/l

0.65

3235

22979

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

813

3852

2.13

85.92

1.7

1.5

144.27

148.16

au/ml

0.34

204

1158

(3020682) Albumin/Creatinine [Ratio] in Urine

8986

74177

1.31

85.56

5.0

4.2

15.49

8.70

mg/mmol

16.88

6073

46597

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2817

19144

1.52

85.17

3.0

2.5

0.55

0.43

e6/l

1.37

2722

18380

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

633

2717

2.34

85.10

1.6

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1187

6471

1.86

83.95

1.4

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1170

6357

1.87

83.63

4.3

3.3

2.45

2.14

index

0.46

674

3234

(3024522) Salmonella sp identified in Specimen by Organism specific culture

630

2726

2.33

83.14

1.6

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1172

6385

1.86

83.05

1.5

12.14

14.50

iu/ml

0.23

148

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

686

3080

2.24

82.94

2.3

2.2

31.61

32.74

7.65

681

3060

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1180

6458

1.85

82.41

1.4

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

298

879

3.39

81.57

44.3

40.9

6.97

7.25

ug/l

1.53

264

793

(3016650) Hepatitis A virus Ab [Presence] in Serum

726

3366

2.17

81.07

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

22238

208720

1.45

80.78

37.7

20.1

139.11

139.64

mmol/l

151.91

21946

204460

(3025468) Yersinia sp identified in Specimen by Organism specific culture

600

2600

2.32

78.91

1.6

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

22252

209066

1.44

78.50

38.0

20.3

3.99

3.98

mmol/l

1.15

21940

204469

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1536

9214

1.70

78.12

2.3

2.4

2.97

2.91

g/l

1.65

1408

8273

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

600

2613

2.31

77.99

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

8749

72615

1.30

77.86

4.1

3.5

80.67

48.66

mg/l

16.99

6092

46909

(3005988) Vibrio sp identified in Specimen by Organism specific culture

600

2616

2.31

77.79

1.6

1.4

—

(3042733) HLA Ab [Presence] in Serum

237

621

3.81

77.50

4.0

5.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

968

5073

1.93

77.22

1.6

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

20449

189595

1.36

76.57

6.4

5.3

1.95

mu/l

0.09

19000

174651

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

719

3403

2.13

76.15

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

567

2435

2.34

76.13

3.8

3.5

5.85

11.67

nmol/l

1.10

545

2363

(3020717) Zinc [Moles/volume] in Serum or Plasma

334

1102

3.03

75.94

2.8

1.4

15.41

22.82

umol/l

7.66

316

1019

(3019150) Specific gravity of Urine by Refractometry

6438

51466

1.32

74.80

5.3

4.2

1.02

1.17

kg/l

1.62

4583

34214

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1182

6679

1.79

74.22

1.6

1.5

2.87

7.46

iu/ml

0.67

233

1326

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1424

8489

1.70

74.03

2.2

2.3

10.35

10.23

g/l

0.42

1280

7459

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

409

1532

2.68

73.49

1.1

289.53

288.06

mg/l

0.13

373

1389

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

843

4294

1.98

73.06

1.6

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

841

4282

1.98

72.98

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2110

13922

1.55

72.48

1.2

—

(3013512) EKG study

9004

75632

1.28

71.08

4.9

3.8

0.71

0.77

0.21

196

(3022806) Fractional oxyhemoglobin in Capillary blood

591

2672

2.22

70.25

2.3

1.8

88.53

89.62

3.25

577

2637

(40768441) Liver Pathology biopsy report

395

1490

2.66

70.01

1.9

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1398

8422

1.68

69.79

2.4

2.5

0.85

0.94

g/l

0.40

1207

7147

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

789

4002

1.99

69.20

1.7

1.6

—

(40761536) Microorganisms panel - Urine sediment

2508

17344

1.48

68.73

5.5

4.1

—

(4035726) Immunohistochemistry procedure

2668

18681

1.47

68.63

1.5

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1414

8600

1.67

68.03

2.0

1.8

6.38

7.63

iu/ml

0.94

326

2062

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

701

3455

2.04

66.62

1.6

1.4

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

104

154

6.72

65.96

3.1

1.8

55.64

62.59

0.76

102

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2493

17359

1.47

65.82

3.6

2.8

60.08

64.41

ml/min/173m2

5.83

1189

7411

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

518

2282

2.28

65.55

1.3

1.2

63.68

64.70

u/l

0.10

470

1991

(3011397) Hemoglobin [Presence] in Urine by Test strip

6629

53975

1.30

65.52

4.8

3.9

0.40

0.25

0.55

564

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

356

1325

2.69

64.82

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

928

5077

1.84

64.71

1.5

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

271

871

3.11

64.53

33.0

29.7

113.42

115.69

ug/l

0.23

223

724

(4062490) Immunoglobulin typing, IgG

487

2104

2.32

64.52

1.6

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1343

8177

1.66

64.27

2.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

796

4157

1.93

64.09

1.2

1.3

37.50

163.10

titre

—

(44790047) Parainfluenza type 1 nucleic acid detection

605

2867

2.12

63.87

1.7

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

7368

60978

1.28

63.68

3.9

3.0

0.14

0.08

1.29

201

1592

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

791

4133

1.93

63.59

1.2

1.3

298.92

283.67

titre

0.06

334

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

351

1310

2.68

63.57

1.3

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

604

2866

2.12

63.55

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

604

2867

2.12

63.49

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

604

2867

2.12

63.49

1.7

1.5

—

(3045716) Anion gap in Serum or Plasma by calculation

528

2382

2.22

63.11

3.8

2.9

11.08

10.68

mmol/l

1.26

520

2351

(3024139) IgG subclass 3 [Mass/volume] in Serum

491

2151

2.29

62.97

1.6

1.4

0.42

0.43

g/l

0.18

345

1538

(3028192) IgG subclass 2 [Mass/volume] in Serum

491

2151

2.29

62.97

1.6

1.4

2.98

2.95

g/l

0.12

341

1542

(3027135) IgG subclass 1 [Mass/volume] in Serum

491

2152

2.29

62.91

1.6

1.4

6.91

6.81

g/l

0.19

344

1538

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

613

2942

2.09

62.59

1.6

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

393

1575

2.50

61.54

1.1

—

(3004809) Band form neutrophils/Leukocytes in Blood

742

3863

1.93

60.29

3.6

3.5

1.68

1.54

0.46

676

3420

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1182

7078

1.69

60.20

2.3

0.05

0.03

g/l

0.51

1070

6329

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1282

7843

1.65

60.15

1.3

1.2

0.72

1.00

u/ml

0.51

101

646

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

408

1690

2.42

59.49

1.2

164.17

173.27

titre

0.09

284

(3008037) Lactate [Moles/volume] in Venous blood

1003

5766

1.76

59.21

4.9

3.2

1.65

1.60

mmol/l

0.73

977

5631

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

407

1690

2.41

59.02

1.2

268.57

106.54

titre

0.71

(3004716) Salmonella sp identified in Stool by Organism specific culture

1455

9230

1.60

58.92

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1141

6807

1.69

58.92

2.3

2.4

0.00

g/l

0.34

1005

5942

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

387

1572

2.46

58.89

2.3

1.9

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

121

7.15

58.46

3.1

1.8

14.62

17.70

0.30

(3003694) ABO and Rh group [Type] in Blood

7205

59960

1.27

58.32

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1404

8864

1.60

57.98

1.8

1.9

40.62

39.13

u/l

1.74

1240

7779

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

882

4918

1.81

57.76

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1075

6356

1.71

57.37

2.4

0.00

g/l

-0.00

1004

5926

(3010015) Selenium [Moles/volume] in Serum or Plasma

108

192

5.60

57.10

2.9

1.8

1.28

1.33

umol/l

0.36

137

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

874

4877

1.81

57.09

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

874

4877

1.81

57.09

1.5

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4708

37200

1.31

56.86

1.4

1.3

37.86

35.19

iu/ml

0.20

1425

11135

(3037121) Protein [Mass/volume] in Urine

1264

7832

1.63

56.33

3.7

3.3

1066.50

475.49

mg/l

1.29

680

3593

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

280

990

2.83

56.31

2.9

1.9

140.96

122.40

umol/l

0.38

138

513

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1883

12784

1.50

56.00

3.5

3.4

4.38

4.46

pmol/l

2.81

1683

11442

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

851

4744

1.81

55.77

1.7

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4391

34481

1.32

55.25

1.4

1.3

8.98

12.37

u/ml

3.01

1670

12991

(3005322) IgE [Units/volume] in Serum or Plasma

1905

13026

1.49

54.65

1.4

1.3

285.96

258.99

u/ml

0.37

1774

12079

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1424

9170

1.57

53.98

2.3

2.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

355

1448

2.45

53.58

4.0

3.5

153.36

173.41

nmol/l

0.32

347

1428

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

595

2991

2.00

53.53

1.6

1.5

—

(3019225) pH of Specimen

2890

21426

1.38

53.01

5.5

4.2

7.36

0.01

2234

15308

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

674

3551

1.91

52.84

1.4

1.5

13.51

13.16

u/ml

0.03

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1325

8453

1.59

52.26

2.2

1.9

—

(3024932) HLA-DR beta [Type]

196

589

3.32

52.25

1.1

—

(3044889) 12 lead EKG panel

15938

145591

1.23

52.07

5.2

4.3

2.25

2417.14

1.17

316

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1376

8890

1.57

51.36

7.4

4.2

24.38

24.77

mmol/l

4.80

1272

8148

(3016038) Potassium [Moles/volume] in Urine

365

1543

2.37

50.91

2.1

1.2

33.22

34.73

mmol/l

0.62

321

1331

(3051651) Icteric interference index of Serum or Plasma

319

1269

2.51

50.82

4.5

3.7

0.80

0.92

index

1.03

314

1242

(40762365) Oxygen content in Arterial blood by calculation

135

320

4.20

50.81

3.7

3.0

14.13

14.90

ml/dl

2.23

126

296

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

765

4252

1.81

50.61

3.1

1.8

0.84

0.86

nmol/l

0.18

645

3583

(3024471) HLA-A [Type]

197

606

3.24

50.59

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

553

2774

2.00

50.07

6.9

9.3

7.57

7.52

mmol/l

0.09

463

2305

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

445

2074

2.15

49.10

1.5

1.3

1.38

1.46

nmol/l

0.72

403

1866

(3045683) HLA typing for celiac disease panel - Blood or Tissue

275

1044

2.63

48.26

1.0

—

(3008295) Osmolality of Serum or Plasma

497

2433

2.05

48.17

1.5

1.4

275.28

278.65

mosm/kgh2o

2.22

381

1830

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1012

6188

1.65

47.45

1.3

54.27

39.61

u/ml

0.68

319

(3000093) Morphology [Interpretation] in Blood Narrative

468

2268

2.07

46.63

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

245

899

2.72

46.01

3.2

1.8

175.35

152.11

2.85

228

847

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

318

1327

2.39

45.71

1.3

1.2

109.97

93.95

u/l

1.69

288

1120

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

948

5792

1.65

44.57

1.3

5.79

6.70

u/ml

0.15

567

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

945

5783

1.65

44.15

1.3

4.91

6.94

u/ml

0.83

135

861

(3001186) Copper [Moles/volume] in Serum or Plasma

169

519

3.25

43.59

1.7

1.2

15.97

16.55

umol/l

0.75

151

450

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

344

1519

2.26

43.43

1.4

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

583

3124

1.87

43.42

3.7

2.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

922

5631

1.65

43.41

1.9

2.0

12.56

11.90

mg/l

0.83

859

5255

(3044242) Glucose [Moles/volume] in Arterial blood

304

1274

2.38

43.31

2.2

1.9

8.48

8.10

mmol/l

0.69

304

1274

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

854

5126

1.68

43.01

1.6

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

216

770

2.80

42.90

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

338

1492

2.26

42.71

1.4

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

196

666

2.93

42.52

3.1

1.9

195.52

172.70

1.70

188

632

(3017569) Oxygen content in Arterial blood

299

1255

2.38

42.46

2.3

2.2

14.84

15.93

5.82

299

1255

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

829

4959

1.68

42.29

1.3

3.09

4.59

u/ml

0.66

334

(40757494) Bilirubin.total [Moles/volume] in Blood

272

1098

2.47

42.09

2.8

2.1

30.09

44.69

umol/l

0.79

114

(3017315) Amylase [Enzymatic activity/volume] in Urine

275

1118

2.46

41.91

1.4

1.2

274.49

341.90

u/l

0.59

254

1034

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

121

6.00

41.58

2.5

1.8

181.89

186.90

ug/g

0.06

105

(3004451) EKG impression Narrative

305

1306

2.33

41.41

1.4

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

298

1264

2.35

41.34

1.7

1.5

7.37

6.70

u/l

0.26

235

1011

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

304

1302

2.33

41.25

1.3

1.2

33.51

25.78

u/l

1.29

272

1077

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

18093

168927

1.22

41.23

39.7

20.5

14.25

13.68

307.65

17926

166648

(3038515) Glucose [Moles/volume] in Venous blood

813

4886

1.67

40.75

5.1

3.4

7.80

7.65

mmol/l

0.73

790

4776

(3051611) Lipemic interference index of Serum or Plasma

448

2251

1.99

40.44

4.5

3.5

12.77

13.48

index

0.73

314

1244

(3045414) Leukocytes [Presence] in Urine

2795

21438

1.33

40.34

2.5

2.1

0.02

estimate

0.14

532

4190

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

20493

193980

1.25

40.14

29.3

16.7

78.22

78.91

ml/min/173m2

3.84

19482

179358

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

400

1938

2.06

39.94

1.5

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

635

3584

1.78

39.93

1.6

1.4

28.78

41.04

g/l

0.83

569

3250

(3027456) Digoxin [Moles/volume] in Serum or Plasma

847

5186

1.64

39.48

3.6

3.3

0.81

nmol/l

0.10

671

4146

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

327

1474

2.22

39.32

1.3

81.60

82.38

0.07

(3042111) Morphology [Interpretation] in Bone marrow Narrative

665

3828

1.74

39.06

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

150

460

3.25

38.83

2.7

2.3

588.45

417.22

ug/l

0.17

150

460

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

838

5142

1.64

38.73

2.4

171.98

108.66

ug/min

2.81

503

2998

(3043410) Blood group antigens tested for on Red Blood Cells

175

589

2.96

38.67

2.2

1.8

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

127

351

3.60

38.67

2.9

2.7

1747.09

1326.70

u/l

0.18

118

310

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

184

638

2.87

38.53

3.8

3.9

7.44

8.52

mg/l

1.44

145

508

(3020876) Protein [Mass/time] in 24 hour Urine

539

2928

1.84

38.48

2.7

2.4

1.38

1.19

g/24h

0.87

358

1687

(3023199) Leukocytes [#/volume] in Pleural fluid

567

3135

1.81

38.22

1.6

1.4

4533.70

2800.96

e6/l

0.47

420

2208

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

854

5309

1.62

37.44

1.3

23.71

11.42

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

419

2121

1.98

37.07

2.5

28.79

25.06

iu/ml

0.27

233

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

238

959

2.48

37.04

1.7

1.5

3318671.81

2144185.77

iu/ml

0.47

(21494890) Protein electrophoresis panel - 24 hour Urine

461

2418

1.91

36.73

1.9

2.1

—

(21494755) Public health laboratory ask at order entry panel

1074

15714

0.66

36.63

1.3

1.4

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

109

5.93

36.62

1.2

1243.91

1010.56

u/l

0.09

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

169

577

2.92

36.43

2.8

2.9

167.63

150.66

au/ml

0.17

(3020564) Creatinine [Moles/volume] in Serum or Plasma

22531

216236

1.29

35.80

39.4

22.1

86.07

80.04

umol/l

53.07

22310

213372

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

173

611

2.82

35.07

1.3

1.2

104.58

105.83

0.14

159

569

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1373

19000

0.70

34.65

1.8

1.9

3.44

3.48

ratio

0.58

1057

14669

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

182

4.54

34.64

4.0

3.3

25.48

22.10

mg/l

0.91

173

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

169

594

2.83

34.57

1.3

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

193

728

2.64

34.47

3.2

2.9

4.89

4.94

kpa

0.19

193

728

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

536

3009

1.78

34.37

1.3

0.29

0.24

nmol/l

0.27

211

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22293

213836

1.28

34.32

19.2

12.2

26.46

26.00

u/l

1.80

21859

207104

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

202

783

2.57

34.15

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method Nominal

809

5077

1.60

34.12

3.4

2.9

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

728

4457

1.64

33.96

1.3

1.2

32.12

47.95

u/ml

1.88

404

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

192

729

2.63

33.85

3.2

2.9

10.25

10.21

kpa

0.05

192

729

(3028308) Erythrocytes [#/volume] in Pleural fluid

504

2794

1.81

33.72

1.5

1.4

64068.24

55090.28

e6/l

0.30

306

1588

(3045788) Cell count panel - Pleural fluid

463

2516

1.84

33.07

1.6

1.4

—

(3023419) Bacteria identified in Sputum by Culture

520

2929

1.78

32.99

2.9

2.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

331

1616

2.05

32.47

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

164

587

2.78

32.46

1.2

84.35

86.98

0.31

281

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

205

827

2.47

31.90

1.1

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

468

2586

1.81

31.68

1.3

0.20

0.21

nmol/l

0.41

352

2066

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

660

4015

1.65

31.60

1.2

1.3

35.14

33.45

u/l

0.16

582

3462

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

432

2334

1.85

31.46

1.8

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

164

597

2.74

31.45

1.2

1.1

84.14

88.31

0.95

278

(3002256) Pathology report gross observation

3570

29112

1.25

31.31

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

424

2287

1.85

31.04

3.0

2.2

14.71

7.96

umol/l

3.14

330

1699

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

515

2950

1.75

30.85

1.3

0.62

2.24

nmol/l

1.34

488

2843

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

356

1819

1.96

30.74

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

956

6386

1.50

30.47

2.6

2.3

4469.51

6103.96

u/l

1.08

303

2478

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

396

2104

1.88

30.41

3.0

2.8

—

(40768446) Kidney Pathology biopsy report

201

822

2.44

30.40

1.8

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

522

3018

1.73

30.26

1.3

1.2

4.18

3.92

u/ml

0.12

242

1133

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

970

13961

0.68

30.23

1.6

1.7

3.28

3.44

mmol/l

4.02

661

9585

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

403

2159

1.87

30.16

1.8

1.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

108

317

3.39

30.10

1.7

1.9

48.71

48.22

pmol/l

0.02

267

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1441

10424

1.39

29.98

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

163

4.45

29.84

4.0

3.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

850

5568

1.53

29.71

2.0

1.9

4.89

6.73

iu/l

0.41

347

2197

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

133

448

2.96

29.48

1.5

1.3

108.71

105.69

0.36

127

430

(3052592) Norovirus Ag [Presence] in Stool

127

419

3.02

29.20

1.5

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

545

3222

1.69

29.14

1.2

1.1

2386.68

4258.65

iu/ml

0.20

106

649

(3017354) Segmented neutrophils/Leukocytes in Blood

450

2521

1.78

29.13

3.7

3.5

58.50

57.78

0.28

396

2130

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

236

1056

2.23

29.04

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

236

1056

2.23

29.04

1.5

1.4

—

(3011412) CD3 cells [#/volume] in Blood

379

2016

1.88

29.02

2.3

2.5

1110.71

1163.83

e6/l

0.61

342

1758

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

438

2441

1.79

28.86

1.4

1.3

471.12

469.25

u/l

0.00

408

2322

(21494434) Karyotype in Bone marrow

375

1995

1.88

28.71

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

846

5579

1.52

28.67

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

20070

191144

1.20

28.57

8.0

6.6

40.73

39.55

mmol/mol

48.83

18767

177891

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

189

774

2.43

28.53

2.2

1.8

11464.45

35350.76

u/ml

0.71

115

(3038177) Helicobacter pylori Ab [Presence] in Serum

527

3107

1.70

28.48

1.3

1.2

—

(4281824) Cell count and differential, peritoneal fluid

385

2077

1.85

28.22

1.3

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

254

1185

2.14

28.18

1.2

1.1

33.81

23.73

u/l

0.98

229

1040

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1765

13320

1.34

28.03

1.3

1.2

116.33

133.39

u/ml

1.08

622

4890

(3000330) Specific gravity of Urine by Test strip

1552

11501

1.36

27.79

5.0

3.5

1.02

ratio

3.34

1408

10345

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

255

1199

2.12

27.73

1.2

1.1

93.63

84.00

u/l

0.69

229

1058

(3010838) Calcium [Moles/time] in 24 hour Urine

592

3628

1.63

27.57

1.9

4.25

4.95

mmol/24h

5.77

510

3207

(3039162) Centromere protein B Ab [Units/volume] in Serum

447

2541

1.76

27.55

1.4

1.3

62.12

54.56

u/ml

0.22

162

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

253

1196

2.11

27.14

1.4

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

253

1196

2.11

27.14

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

354

1885

1.88

27.06

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

354

1885

1.88

27.06

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

354

1885

1.88

27.06

1.7

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

469

2718

1.73

27.01

1.1

115.54

116.16

0.13

430

2453

(3042631) Mycobacterium sp identified in Specimen

523

3139

1.67

26.45

2.7

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

122

417

2.91

26.39

1.2

72.87

70.55

0.20

123

(4198724) Urine methamphetamine measurement

190

809

2.34

26.34

3.5

2.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

271

3.41

26.28

4.8

5.8

53.81

42.61

ug/min

0.84

220

(3026389) Candida sp identified in Specimen by Organism specific culture

522

3141

1.66

26.15

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

323

1691

1.91

26.03

1.3

1.2

103.91

108.86

pmol/l

0.90

323

1691

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

303

1557

1.94

25.82

2.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

498

2970

1.68

25.82

1.3

1.2

4.02

3.93

u/ml

0.07

267

1384

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

121

418

2.88

25.69

1.2

83.05

80.69

0.19

128

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2124

16641

1.29

25.64

1.5

—

(4195642) Thrombophilia screening test

463

2721

1.70

25.37

1.2

—

(3045424) Erythrocytes [Presence] in Urine

1466

10924

1.35

25.29

2.4

2.1

0.02

0.12

estimate

0.70

391

3202

(3008757) Leukocyte morphology finding [Identifier] in Blood

420

2417

1.74

24.84

3.8

3.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

425

2459

1.73

24.66

1.4

1.3

6.46

6.32

mmol/l

0.49

402

2291

(3006270) Folate [Moles/volume] in Blood

327

1751

1.86

24.61

1.2

341.08

346.01

nmol/l

0.16

259

1423

(3042517) Benzodiazepines panel - Urine

198

3.77

24.58

3.3

2.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

340

1845

1.84

24.53

1.5

1.4

14.58

13.18

u/l

2.70

326

1780

(3012565) Volume of 24 hour Urine

220

1027

2.14

24.44

2.4

2.1

1864.00

1934.68

0.44

200

899

(40768806) Pleura Pathology biopsy report

455

2691

1.69

24.37

1.6

1.5

—

(4268621) Lupus anticoagulant assay

374

2094

1.78

24.34

2.3

—

(3012441) Differential panel - Pleural fluid

456

2704

1.69

24.19

1.6

1.5

—

0.80

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

476

2860

1.66

24.02

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

890

6148

1.45

23.97

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

283

1468

1.92

23.50

1.6

1.4

—

(3022621) pH of Urine by Test strip

2187

17432

1.27

22.89

3.3

2.7

6.08

6.05

0.88

1576

11891

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

346

1929

1.79

22.88

1.3

12.72

14.17

u/l

0.33

308

1785

(1175426) CD3 cells/Lymphocytes in Blood

304

1636

1.85

22.57

2.2

72.48

71.52

0.46

294

1561

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

100

335

2.97

22.50

2.6

2.8

42.79

49.89

mg/l

0.15

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

208

993

2.09

21.86

3.5

3.4

1.52

1.26

1.10

208

993

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

136

544

2.49

21.73

1.3

1.2

14.57

12.35

pmol/l

0.31

196

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

245

3.29

21.66

1.3

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

345

5805

0.58

21.65

1.1

0.65

0.62

ratio

0.29

760

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

478

2965

1.61

21.30

1.3

1.2

9.36

10.25

u/ml

0.04

118

(3009466) Valproate [Moles/volume] in Serum or Plasma

483

3019

1.60

20.86

5.2

5.1

353.77

352.24

umol/l

0.08

421

2601

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

218

1082

2.01

20.64

1.1

1.07

ratio

0.03

195

882

(3016750) Collection duration of Urine

237

1212

1.95

20.60

2.2

505.66

498.05

min

0.64

176

895

(3004616) Nuclear Ab [Presence] in Serum

436

2670

1.63

20.49

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

117

449

2.59

20.41

2.1

1.8

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

125

4.21

20.31

1.0

1.1

39.33

36.34

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

125

4.21

20.31

1.0

1.1

25.45

20.94

u/ml

0.32

(3010503) CD19 cells [#/volume] in Blood

237

1219

1.94

20.27

2.2

2.6

145.48

391.19

e6/l

1.76

229

1173

(3035947) Staphylolysin Ab [Units/volume] in Serum

217

1083

2.00

20.24

1.1

3.12

4.23

iu/ml

0.76

(3006576) Bicarbonate [Moles/volume] in Blood

168

764

2.19

20.05

7.8

6.1

24.27

24.94

mmol/l

1.14

155

689

(1761482) Bacteria [#/volume] in Urine by Culture

812

5704

1.43

20.02

6.0

4.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

248

1301

1.90

20.00

1.5

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

311

1753

1.77

19.89

1.6

—

(3044927) Protein electrophoresis panel - Urine

392

2355

1.66

19.88

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

310

1749

1.77

19.76

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

246

1294

1.89

19.68

1.6

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

253

1349

1.87

19.42

1.6

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

117

461

2.53

19.36

1.2

—

(3004775) Volume in Urine collected for unspecified duration

302

1702

1.77

19.34

2.3

793.05

658.72

3.97

207

1134

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

411

2518

1.63

19.31

1.3

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

268

1466

1.82

18.97

2.6

2.7

213.45

232.83

e6/l

0.66

238

1234

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

534

3491

1.53

18.97

1.2

0.42

0.92

2.64

108

(3008116) Ketones [Moles/volume] in Urine by Test strip

122

496

2.45

18.90

1.6

1.4

0.34

0.28

mmol/l

0.23

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

226

3.21

18.86

1.6

1.2

—

(3045142) Bone marrow Pathology biopsy report

417

2580

1.61

18.84

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

266

1455

1.82

18.84

1.4

13.89

13.21

umol/l

0.76

257

1364

(3014148) Varicella zoster virus Ab [Titer] in Serum

428

2665

1.60

18.83

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

364

2177

1.67

18.81

1.3

1.2

26.57

31.81

nmol/l

—

(3016244) Insulin [Units/volume] in Serum or Plasma

227

1181

1.92

18.80

3.1

3.2

23.63

25.37

mu/l

0.36

213

1108

(40761539) Cells [Type] in Urine sediment by Light microscopy

127

530

2.38

18.59

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

442

2786

1.58

18.48

2.2

2.1

6.00

8.90

titre

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

351

2105

1.66

17.97

1.1

96.60

96.06

0.13

330

1968

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

296

2.86

17.94

1.8

2.4

1.43

1.42

mmol/l

0.02

206

(3006571) Granulocytes/Leukocytes in Synovial fluid

426

2688

1.58

17.75

1.6

1.5

59.91

59.78

0.02

270

1697

(3003329) Lymphocytes/Leukocytes in Synovial fluid

340

2031

1.67

17.68

1.6

1.5

26.71

29.55

0.80

216

1243

(21494815) CD4 cells/Lymphocytes in Specimen

314

1839

1.70

17.59

2.2

2.3

38.27

38.19

0.03

305

1809

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

367

2.63

17.49

1.9

1.4

1493.75

5654.29

u/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

258

1432

1.80

17.45

2.5

2.6

505.83

514.38

e6/l

0.09

212

1141

(3013336) Amino acids [Identifier] in Serum or Plasma

5.19

17.25

3.4

2.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

229

1230

1.85

17.24

1.6

1.5

1.15

1.25

nmol/l

0.70

172

911

(3000764) Benzodiazepines [Presence] in Urine

986

7337

1.35

17.18

3.0

2.0

—

(3016879) Cocaine [Presence] in Urine

930

6861

1.36

17.14

3.1

2.1

—

(3000492) Spirometry study

2392

19868

1.21

16.95

1.6

1.5

—

17.22

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

148

3.63

16.88

3.6

3.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

679

4768

1.42

16.83

1.5

1273.20

2626.50

e6/l

0.75

558

3763

(3011985) Renin [Units/volume] in Plasma

472

3087

1.53

16.79

1.6

1.5

49.14

67.83

mu/l

1.85

418

2761

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

170

835

2.03

16.68

1.2

1.1

14.24

15.67

u/ml

0.05

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

759

5446

1.39

16.62

1.4

519.02

549.39

mg/l

0.58

723

5201

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

323

1936

1.66

16.62

1.2

—

(3035880) pH of Pleural fluid

242

1341

1.80

16.49

1.4

1.3

7.42

7.40

0.46

171

947

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

669

4711

1.42

16.34

1.4

1.5

33.08

30.04

e6/l

0.07

502

3495

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

133

601

2.20

16.23

1.1

—

(3028300) Cannabinoids [Presence] in Urine

987

7411

1.33

16.20

3.1

2.0

—

(3020393) Adenovirus Ag [Presence] in Stool

293

2.75

15.98

2.0

1.3

—

(3027008) Opiates [Presence] in Urine

983

7393

1.33

15.96

2.8

2.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

679

4818

1.41

15.89

1.4

3.81

3.76

mmol/l

0.61

637

4565

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

139

645

2.14

15.88

3.2

2.2

9.35

9.24

mg/l

0.09

119

540

(40768443) Skin Pathology biopsy report

1296

10139

1.28

15.72

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

206

1104

1.86

15.67

1.7

1.5

13.26

8.66

ug/l

1.11

189

1007

(3002619) Bacteria identified in Specimen by Culture

129

585

2.19

15.62

1.5

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

304

1825

1.66

15.58

1.6

22.41

26.18

u/ml

0.77

368

(1761868) Lipid panel - Serum or Plasma

6844

74083

0.89

15.57

3.6

3.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

360

2256

1.59

15.52

1.2

60.76

41.56

u/ml

0.60

114

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

306

1848

1.65

15.33

1.9

1.7

5.15

3.95

mg/l

2.04

288

1764

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

144

3.52

15.29

1.2

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

285

1694

1.68

15.19

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

266

1554

1.71

15.12

1.3

241.33

542.79

titre

1.28

136

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

272

1600

1.69

15.08

1.2

—

(3007461) Platelets [#/volume] in Blood

22714

220979

1.18

14.91

48.5

25.4

248.22

247.27

e9/l

1.14

22404

215917

(3035941) MCH [Entitic mass]

22716

221027

1.18

14.75

48.3

25.3

30.25

30.35

11.25

22531

218353

(3017704) Immunofixation for Urine

225

1264

1.77

14.71

1.4

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

22720

221085

1.18

14.65

49.0

25.6

127.31

134.72

g/l

307.65

22535

218465

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

278

1658

1.67

14.65

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

22716

221044

1.18

14.64

49.7

25.9

38.30

40.52

133.71

22522

218274

(3024731) MCV [Entitic mean volume] in Red Blood Cells

22715

221034

1.18

14.64

48.3

25.3

91.34

91.20

4.18

22533

218360

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

287

1727

1.66

14.61

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

22716

221051

1.18

14.60

48.5

25.4

4.26

4.47

e12/l

307.65

22345

215162

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

278

1661

1.67

14.55

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

265

1564

1.69

14.53

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

258

1512

1.70

14.52

1.3

36.43

64.60

titre

1.12

100

(3027944) Amphetamines [Presence] in Urine

959

7288

1.32

14.50

3.0

2.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

108

3.86

14.42

1.0

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

224

1265

1.76

14.39

2.3

2.5

1499.08

1152.77

u/ml

0.76

219

1245

(3010813) Leukocytes [#/volume] in Blood

22716

221089

1.18

14.37

48.5

25.4

7.06

6.84

e9/l

25.92

22352

215228

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

366

2346

1.56

14.35

4.2

3.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

345

2.51

14.34

6.6

6.0

21033.00

4157.00

iu/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

271

1616

1.67

14.30

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

867

6508

1.33

14.29

1.9

1.7

332.06

297.26

mu/l

1.39

793

5931

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

306

2.60

14.20

1.5

6.75

188469.10

nmol/l

1.46

260

(3036603) Volume of Urine

271

1620

1.67

14.17

1.6

1841.89

1938.06

1.12

264

1580

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

343

2181

1.57

13.94

1.4

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

123

577

2.12

13.74

10.2

7.2

5.90

5.98

kpa

0.48

111

506

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

20207

195195

1.13

13.58

5.9

5.3

6.15

5.98

mmol/l

48.56

18532

178518

(3001964) Herpes simplex virus Ag [Presence] in Specimen

124

591

2.09

13.31

1.3

1.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

507

3529

1.43

13.29

1.8

1.6

—

(3016228) CD19 cells/cells in Blood

153

788

1.93

13.23

1.9

2.0

7.32

8.55

0.67

148

761

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

205

2.91

13.22

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

244

1447

1.68

13.19

2.6

0.63

0.67

e9/l

0.46

230

1377

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

137

681

2.00

13.13

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

146

744

1.95

13.03

1.2

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

411

2.30

12.97

3.0

2.6

1.18

1.19

mmol/l

0.59

391

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

112

3.64

12.96

4.2

3.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

110

506

2.16

12.95

10.6

7.1

5.89

5.48

kpa

0.70

110

506

(3009214) Lutropin [Units/volume] in Serum or Plasma

786

5913

1.33

12.80

1.5

11.51

9.74

u/l

2.50

628

4654

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

107

490

2.17

12.75

2.2

1.8

93.50

128.37

au/ml

0.46

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2958

25650

1.16

12.60

11.9

7.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

328

2115

1.55

12.59

1.7

385.25

358.92

mu/l

0.41

258

1693

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

119

3.51

12.59

1.1

68.68

102.96

u/l

0.24

(3003129) Base excess in Capillary blood by calculation

405

2731

1.48

12.57

2.9

2.3

0.41

0.46

mmol/l

0.08

375

2617

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

130

645

2.00

12.54

1.8

1.9

1.61

1.83

ratio

0.96

125

615

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

303

1924

1.57

12.45

1.3

1.2

86.83

76.21

u/ml

0.17

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

106

3.65

12.43

11.6

10.7

134.80

264.18

e6/l

0.58

(4024509) Urine culture

1278

10277

1.25

12.32

2.2

1.9

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

265

2.59

12.21

1.5

1.3

70.69

73.40

0.30

217

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

171

940

1.81

12.12

1.6

3.69

7.13

nmol/l

0.70

140

784

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

118

3.45

12.02

1.1

1.15

1.12

u/field

0.09

(3038026) Centromere Ab [Units/volume] in Serum

263

1631

1.61

11.97

1.2

23.76

53.36

u/ml

0.90

108

(3028717) Thiamine [Mass/volume] in Blood

268

2.56

11.95

1.2

60.48

63.34

ug/l

0.51

268

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

100

458

2.17

11.94

1.4

1.3

1.18

mmol/l

0.71

100

458

(3008898) HLA-B27 [Presence]

820

6271

1.31

11.90

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

418

2869

1.45

11.87

1.4

1.3

578.13

350.68

pmol/l

0.42

350

2421

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

372

2497

1.49

11.84

1.4

23.93

27.06

u/l

1.06

307

2053

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

224

2.71

11.81

3.6

3.0

1.45

1.16

mg/l

0.43

169

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

170

2.98

11.78

1.3

1.4

1.30

1.14

ml/s/173m2

0.36

114

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

758

5744

1.32

11.77

1.3

202.63

221.15

miu/ml

0.66

271

2495

(3000475) Leukocytes [#/volume] in Synovial fluid

754

5717

1.32

11.66

1.8

1.6

15180.02

14838.55

e6/l

0.07

535

4053

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

417

2872

1.45

11.64

1.2

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

588

4302

1.36

11.57

2.4

1.9

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

197

1147

1.71

11.48

1.3

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

334

2.35

11.43

1.3

1.2

598.77

154.55

u/l

0.44

238

(43055442) Apixaban [Mass/volume] in Serum or Plasma

410

2.21

11.34

1.6

115.75

110.66

ug/l

0.16

346

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

267

1693

1.57

11.10

2.4

2.6

18.23

18.87

nmol/l

0.52

251

1604

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1702

14247

1.20

11.04

2.5

2.4

23.62

21.19

au/ml

0.43

143

1439

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

109

534

2.03

10.96

1.7

10.21

9.35

ug/l

0.96

109

534

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

198

1170

1.68

10.95

1.7

2.0

2.81

2.69

u/field

0.07

150

816

(3034988) Calcium [Moles/volume] in Capillary blood

404

2.19

10.91

3.3

2.5

1.17

1.18

mmol/l

0.93

385

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

4.11

10.90

1.1

2.25

0.87

u/field

0.61

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

194

1143

1.69

10.85

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

194

1143

1.69

10.85

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

194

1143

1.69

10.85

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

198

1174

1.68

10.81

2.4

2.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

138

738

1.86

10.75

1.3

447.87

195.11

ug/l

0.54

402

(3042010) Triglyceride [Moles/volume] in Pleural fluid

370

2.23

10.65

1.3

1.2

1.02

1.31

mmol/l

0.21

238

(3005532) Lymphocytes/Leukocytes in Pleural fluid

155

862

1.79

10.64

1.5

1.4

63.98

63.88

0.01

119

714

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

334

2245

1.48

10.62

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

194

1150

1.68

10.62

3.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

193

1143

1.68

10.60

1.8

—

(3047189) Immunofixation for 24 hour Urine

183

1069

1.70

10.58

1.5

1.7

—

(3023383) Lactate [Moles/volume] in Pleural fluid

140

759

1.83

10.46

1.5

1.3

3.04

3.50

mmol/l

1.07

125

699

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

128

675

1.89

10.43

1.5

1.4

15.77

15.28

pmol/l

0.17

101

561

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

106

524

2.01

10.42

1.8

1.6

0.40

ug/l

0.02

362

(3008536) Aspergillus sp Ab [Presence] in Serum

445

2.10

10.39

2.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.37

10.27

3.7

4.6

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

207

2.64

10.21

1.3

1.2

0.06

0.38

u/ml

—

(3023511) Choriogonadotropin [Units/volume] in Urine

432

3070

1.40

10.20

1.6

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1561

13075

1.20

10.06

1.3

48.19

54.03

au/ml

0.44

811

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

283

1862

1.51

10.01

1.9

2.1

1.51

1.81

u/field

0.67

165

1020

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

175

1026

1.70

10.01

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1171

9550

1.23

9.95

3.8

3.6

50.03

68.08

u/ml

2.12

1136

9207

(3001893) Eosinophils/Leukocytes in Pleural fluid

136

743

1.82

9.93

1.5

1.4

2.22

2.72

0.39

102

634

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

402

2839

1.41

9.86

2.4

2.1

24.52

27.41

mg/l

0.63

145

1045

(3035320) C reactive protein [Mass/volume] in Body fluid

269

1757

1.52

9.86

3.2

2.8

31.52

29.37

mg/l

0.37

204

1289

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

166

2.81

9.86

1.5

1.4

—

(3006245) CD3-CD19+ cells/cells in Blood

153

868

1.75

9.85

2.9

2.4

12.29

11.41

0.29

145

811

(3034891) Synovial lining cells/cells in Synovial fluid

176

1039

1.69

9.82

1.5

4.07

3.53

0.16

219

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

125

3.10

9.70

1.7

1.1

58.92

43.11

mg/l

0.72

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

373

2.16

9.64

2.1

16.74

16.48

umol/l

0.08

373

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

200

1227

1.62

9.62

2.6

2.8

40.70

38.48

0.89

120

678

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

441

2.05

9.49

2.3

2.5

7.13

7.69

mmol/l

0.83

271

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

661

5069

1.30

9.49

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

169

997

1.69

9.48

3.0

2.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

134

742

1.80

9.39

1.0

1.1

93.59

96.47

0.53

108

581

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2144

18545

1.16

9.37

2.4

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

315

2159

1.45

9.14

1.5

1.4

118004.90

145838.40

e6/l

0.38

216

1434

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

271

1803

1.50

9.14

1.3

9.71

8.75

mmol/l

2.34

255

1703

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

268

2.34

9.08

2.4

2.8

64.71

79.40

pmol/l

0.52

241

(3027570) Oxalate [Moles/time] in 24 hour Urine

120

3.06

9.04

1.6

1.4

361.51

318.51

umol/24h

0.40

120

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

436

3171

1.37

9.02

1.9

2.0

20.89

25.01

ug/l

0.89

424

3102

(3020911) Cortisol [Moles/time] in 24 hour Urine

124

680

1.81

9.00

1.5

1.4

90.50

208.93

nmol/24h

1.60

124

680

(3018133) Calcium [Moles/volume] in Urine

457

2.00

8.99

2.4

2.3

2.36

2.65

mmol/l

0.70

418

(3024666) Lithium [Moles/volume] in Serum or Plasma

173

1044

1.65

8.93

14.5

13.5

0.60

0.62

mmol/l

0.64

167

950

(3000919) Neutrophils/Leukocytes in Pleural fluid

121

663

1.81

8.81

1.4

22.26

20.83

0.23

103

599

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

272

2.30

8.79

1.6

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

4.62

8.70

8.5

9.3

54.92

45.55

0.60

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19373

187871

1.10

8.67

4.8

4.3

1.31

1.28

mmol/l

5.98

17783

171816

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

167

1009

1.65

8.60

1.1

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

255

1699

1.49

8.57

1.3

2.17

2.14

mmol/l

0.12

232

1570

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

120

664

1.80

8.48

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

153

907

1.68

8.48

2.0

39.00

40.08

g/l

1.57

153

907

(3028433) Virus identified in Specimen by Culture

122

679

1.79

8.46

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

116

640

1.80

8.29

1.4

1.2

138.06

127.95

nmol/l

0.22

461

(3012898) Urea [Moles/volume] in Urine

230

2.38

8.27

1.2

1.4

135.86

168.29

mmol/l

1.05

198

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

4.04

8.14

8.1

8.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

192

1218

1.57

8.12

1.8

1.4

5.81

6.20

u/l

0.18

160

1044

(3002079) Sodium [Moles/time] in 24 hour Urine

157

951

1.64

8.04

1.3

1.2

152.66

161.19

mmol/24h

0.59

157

951

(3026051) Granulocytes/Leukocytes in Pleural fluid

101

541

1.86

7.96

1.6

1.3

21.69

22.12

0.05

444

(3013466) aPTT in Blood by Coagulation assay

3.20

7.93

1.2

1.1

38.48

38.50

0.00

(3000034) Microalbumin [Mass/volume] in Urine

272

1870

1.45

7.84

3.3

3.0

48.60

49.81

mg/l

0.03

195

1367

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

1096

1.59

7.83

1.1

—

(3014271) Vancomycin [Susceptibility]

195

1257

1.54

7.71

3.4

3.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2290

20177

1.14

7.68

2.4

2.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

234

2.29

7.53

1.1

325.18

274.72

u/ml

0.19

(3036071) Salmonella sp Ab [Titer] in Serum

106

587

1.79

7.53

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

266

2.20

7.50

4.2

3.0

40.56

41.10

umol/l

0.06

224

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

157

972

1.61

7.40

1.2

1.3

48.23

65.87

1.01

104

(21491868) Cryoglobulin [Mass/volume] in Serum

126

744

1.68

7.17

1.2

1.55

0.42

g/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

121

707

1.70

7.16

1.2

1.3

35.83

40.59

g/l

2.16

367

(44786800) Granulocytes/Leukocytes in Body fluid

292

2.11

7.09

1.4

1.3

23.34

24.35

0.08

233

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

105

592

1.76

7.05

2.0

1.9

37.04

39.94

u/l

0.09

546

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

1212

1.53

7.04

1.1

—

(3034426) Prothrombin time (PT)

104

585

1.77

7.04

1.2

29.24

28.29

0.87

104

585

(44806071) Cardiolipin IgM antibody measurement

267

2.16

7.03

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

485

1.84

7.02

1.3

1.2

1.44

1.54

mmol/l

0.36

297

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

102

572

1.77

6.98

2.8

3.1

2.13

1.84

ratio

0.61

523

(3000060) B lymphocytes [#/volume] in Blood

113

654

1.72

6.94

2.9

2.4

0.45

0.90

e9/l

0.44

331

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

346

2536

1.36

6.93

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.00

6.91

1.3

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

369

1.97

6.90

1.5

1.4

14.30

10.90

0.37

192

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

377

1.95

6.85

7.4

7.1

10.31

10.48

0.23

377

(37208534) Antinuclear antibody arbitrary concentration in serum

119

702

1.69

6.82

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.94

6.68

1.2

1.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

163

1046

1.55

6.65

2.1

114.33

109.51

ug/min

0.04

240

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

119

711

1.66

6.52

3.0

2.6

141.51

147.02

nmol/l

0.20

102

630

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

325

2402

1.35

6.22

1.9

1.8

3877.33

2113.10

titre

0.43

(3022229) Phosphate [Moles/volume] in Urine

166

2.39

6.21

1.8

2.6

19.94

20.40

mmol/l

0.04

139

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

102

593

1.71

6.21

1.6

1.4

580.39

800.38

mu/l

0.53

565

(3005033) Fetal Nuchal fold Thickness US

224

3131

0.71

6.20

1.5

1.27

1.26

0.12

153

2299

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

115

693

1.65

6.13

1.4

1.3

0.31

0.30

g/l

0.18

568

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

123

755

1.62

6.10

1.1

1.2

—

(3036180) Methadone [Presence] in Urine

5.27

6.09

5.0

2.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.84

6.09

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

186

1256

1.47

6.01

1.1

4.00

7.44

nmol/l

0.95

242

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

216

1501

1.43

6.00

1.1

264.39

273.03

mg/l

0.24

192

1341

(3047352) Trisomy 18 risk [Likelihood] in Fetus

232

3202

0.72

5.97

1.5

—

(3020491) Glucose [Moles/volume] in Blood

219

1529

1.42

5.94

1.9

7.32

6.97

mmol/l

0.65

164

1087

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

109

654

1.66

5.92

1.2

24.33

19.43

0.25

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

102

603

1.68

5.87

1.6

1.4

73.89

72.82

0.46

575

(3043238) Trisomy 21 risk [Likelihood] in Fetus

239

3269

0.72

5.83

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

118

727

1.61

5.79

2.8

3.0

28.59

28.29

umol/l

0.11

549

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4392

46660

0.92

5.78

3.2

3.3

0.80

ug/l

0.10

3032

31750

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

249

2.07

5.77

1.1

1.0

—

(3033099) Centromere Ab [Titer] in Serum

517

1.73

5.75

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1136

9733

1.17

5.71

2.3

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

974

8245

1.18

5.70

1.5

1.4

25.09

26.73

iu/l

0.84

821

6956

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

108

654

1.64

5.68

1.3

113.86

110.45

0.73

588

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

642

5233

1.22

5.66

1.2

3.93

3.83

0.07

630

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

259

2.03

5.59

1.1

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

597

1.66

5.57

1.3

1.7

—

152.38

iu/ml

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

449

1.77

5.56

1.2

225.92

309.63

pmol/l

1.88

326

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

175

1188

1.46

5.54

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

581

4699

1.23

5.53

4.1

3.5

28.33

28.64

mg/l

0.08

436

3301

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

115

2.59

5.53

1.0

0.79

u/ml

0.00

105

(3020123) Porphyrins [Interpretation] in Serum or Plasma

116

2.57

5.44

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

214

1516

1.40

5.39

1.3

1.57

2.18

u/ml

0.39

144

910

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

220

1568

1.40

5.35

1.2

1.1

46.10

41.95

mg/l

0.31

187

1332

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

224

2.08

5.31

1.0

1.1

0.02

0.40

u/ml

1.20

149

(40757373) Influenza virus identified in Isolate

441

1.76

5.31

1.4

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1340

11688

1.15

5.30

2.5

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

130

840

1.54

5.24

2.1

2.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.37

5.22

1.2

1.1

—

mmol/l

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

200

1412

1.41

5.16

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

261

1.98

5.12

1.7

1.8

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.72

5.02

1.3

1.4

0.71

0.64

u/field

—

(3026480) Teichoate Ab [Titer] in Serum

203

2.10

5.00

1.1

—

2.25

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

103

639

1.60

4.98

1.5

1.4

62.49

57.29

0.77

541

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

159

2.25

4.93

1.6

1.20

1.93

mg/l

0.70

115

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

127

829

1.52

4.92

2.1

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

127

829

1.52

4.92

2.1

2.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

102

635

1.60

4.87

1.1

1.2

908.33

949.25

titre

0.12

134

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.84

4.83

3.6

4.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

396

1.76

4.79

1.2

1.4

96.00

432.91

titre

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

426

1.73

4.77

1.3

1.2

96.93

54.28

mg/l

0.25

314

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

554

1.63

4.76

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

608

1.60

4.75

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

608

1.60

4.75

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

608

1.60

4.75

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

608

1.60

4.75

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

255

1.95

4.74

1.1

15.33

17.56

g/l

1.10

234

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

291

1.88

4.68

1.8

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

299

3826

0.77

4.68

1.5

—

(40765096) Chromosome analysis panel by Banding

106

675

1.56

4.62

1.2

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

244

1.95

4.60

1.2

103.57

99.32

ug/l

0.07

150

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

327

4128

0.78

4.60

1.5

60.40

61.77

ug/l

0.18

268

3472

(4027681) Cerebrospinal fluid IgG ratio and IgG index

166

1160

1.42

4.59

1.3

1.2

0.56

0.66

ratio

1.00

107

676

(37021550) Renin [Units/volume] in Plasma --upright

396

1.73

4.52

1.2

1.3

115.87

85.91

mu/l

0.31

299

(3019832) Treponema pallidum Ab [Presence] in Serum

1976

17819

1.11

4.51

1.9

1.8

—

(36303858) Crystals [Presence] in Urine

4.48

4.51

1.1

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

179

2.11

4.48

1.1

1.2

1.56

1.62

iu/ml

0.06

100

(4212803) Bone marrow aspirate examination

199

2.05

4.47

1.1

—

(40768800) Prostate Pathology biopsy report

427

5213

0.81

4.47

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

104

2.48

4.45

1.2

1.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

219

1612

1.35

4.45

1.5

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

297

1.84

4.42

1.7

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

309

3905

0.78

4.40

1.5

1.12

1.20

ratio

0.80

176

2370

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

309

3905

0.78

4.40

1.5

0.96

0.95

ratio

0.18

174

2354

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

353

2778

1.26

4.39

1.1

3.92

2.70

0.53

387

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

305

1.82

4.38

1.0

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

308

3891

0.78

4.38

1.5

1.10

1.16

ratio

0.45

173

2339

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

255

1926

1.32

4.36

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

110

718

1.52

4.32

1.6

3033.04

3333.33

titre

0.18

111

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

2.54

2.84

mg/l

0.13

113

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

1.40

1.35

mg/l

0.02

108

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

1.07

1.74

mg/l

1.17

120

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

0.88

2.43

mg/l

2.40

125

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

4.56

3.92

mg/l

0.17

105

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

1.14

1.12

mg/l

0.01

116

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

0.95

1.91

mg/l

1.40

103

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

1.43

2.60

mg/l

1.12

117

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

156

2.16

4.29

1.6

2.92

1.84

mg/l

0.37

112

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.07

4.29

1.4

1.7

368.73

233.31

nmol/l

0.24

(3024263) Appearance of Synovial fluid

156

1097

1.41

4.20

1.5

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

376

1.72

4.17

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

17390

169431

1.06

4.15

41.6

21.6

330.66

332.18

g/l

80.49

17291

168330

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.54

4.13

2.0

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

158

2172

0.72

4.12

1.3

—

(3014891) Appearance of Pleural fluid

348

1.74

4.12

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

417

1.67

4.05

2.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

264

1.84

4.00

1.0

1.1

18.10

20.10

u/l

0.48

174

(3025549) Creatine [Moles/time] in 24 hour Urine

168

2.07

3.97

1.6

1.4

—

14.73

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.43

3.97

1.1

1.5

0.89

1.20

u/field

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

382

1.69

3.96

1.1

1.97

5.01

u/ml

0.67

339

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

237

1.89

3.94

1.1

1.0

72.86

79.65

ug/l

0.52

183

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

161

1155

1.39

3.90

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.41

3.89

1.0

1.1

0.54

1.91

u/ml

0.67

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

137

957

1.42

3.87

2.8

2.4

52.79

53.20

umol/l

0.05

118

828

(3020874) Milk IgE Ab [Units/volume] in Serum

164

1183

1.38

3.85

1.1

1.16

2.41

u/ml

0.92

436

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

177

2.02

3.84

1.0

0.16

0.28

u/ml

0.23

114

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

106

2.34

3.82

20.1

7.1

103.28

104.00

g/l

0.11

106

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

456

1.61

3.78

1.1

—

(3001488) Cow milk IgE Ab [Units/volume] in Serum

3.91

3.75

1.0

—

1.30

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

193

1.95

3.72

1.2

1.4

13.89

16.30

pmol/l

0.21

163

(3007919) Fasciola sp Ab [Titer] in Serum

3.56

3.65

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

195

1.93

3.62

2.3

2.2

0.68

ug/l

0.03

195

(3033942) Copper [Moles/time] in 24 hour Urine

2.58

3.57

1.2

1.3

0.91

0.80

umol/24h

—

(3007463) Buprenorphine [Presence] in Urine

2.58

3.57

2.7

5.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.45

3.56

1.5

1.4

—

(3023410) Appearance of Cerebral spinal fluid

274

2152

1.27

3.55

1.6

1.7

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

566

1.53

3.54

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

720

8195

0.87

3.46

1.7

1.6

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.31

3.43

1.1

9.81

8.41

0.97

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

158

2.01

3.41

1.1

0.06

0.04

u/ml

0.38

158

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

151

1099

1.37

3.40

1.5

1.3

3.83

4.82

umol/l

3.19

131

977

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

556

1.52

3.40

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

214

1.86

3.39

1.6

1.7

50.10

46.92

umol/l

0.23

214

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

100

2.28

3.36

1.1

35.50

36.74

0.53

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

100

2.28

3.36

1.1

23.15

20.81

1.53

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

3.72

3.35

6.0

7.3

358.86

478.93

e6/l

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

622

1.49

3.35

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

560

1.51

3.30

1.1

4.25

9.74

u/ml

0.40

331

(3016273) Islet cell 512 Ab [Units/volume] in Serum

127

2.11

3.28

1.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

141

2.04

3.24

1.8

1.4

39.59

37.06

0.12

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

204

1.85

3.20

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

439

1.56

3.15

1.9

2.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

116

2.14

3.15

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

468

3938

1.18

3.13

1.7

1.4

139.22

172.80

pmol/l

1.11

456

3829

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

157

1.96

3.11

1.2

1.1

17.75

9.60

u/l

0.45

157

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

207

1.82

3.08

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

513

1.51

3.08

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

189

1455

1.29

2.95

1.1

7.24

8.54

iu/ml

0.30

351

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

400

1.56

2.93

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

168

1.89

2.91

1.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

211

1.79

2.91

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

3.22

2.90

1.5

1.2

3.19

3.40

mmol/l

0.03

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

653

7378

0.87

2.88

1.5

1.6

1121.96

995.42

mu/l

0.39

539

6278

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

114

2.09

2.87

4.5

5.2

—

(3044009) aPTT.lupus sensitive (LA screen)

162

1.90

2.87

1.3

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

121

2.05

2.85

1.1

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.30

2.85

1.0

—

(3019174) dRVVT (LA screen)

163

1.89

2.82

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

122

890

1.36

2.79

1.1

583.62

445.27

ng/l

0.13

242

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

237

1.72

2.76

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

176

1356

1.29

2.76

1.2

—

(4034850) Laboratory test

740

6510

1.13

2.75

15.1

10.9

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.52

2.73

4.1

6.5

—

(3030703) Everolimus [Mass/volume] in Blood

8.27

2.73

15.0

18.2

5.36

3.87

ug/l

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

2.25

2.71

1.6

1.4

151.38

117.58

ug/l

0.23

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

353

1.58

2.71

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

353

1.58

2.71

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

353

1.58

2.71

1.2

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

246

1.70

2.70

2.4

2.7

—

(3001729) Color of Synovial fluid

174

1.83

2.65

1.6

1.7

—

(44813793) Dust mix specific IgE antibody measurement

184

1437

1.27

2.61

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

197

1.76

2.60

1.4

1.5

18.73

18.34

nmol/l

0.03

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

118

868

1.35

2.58

2.2

2.4

26.04

221.14

ug/l

1.57

111

825

(3035611) Eosinophils/Leukocytes in Synovial fluid

147

1.89

2.58

1.7

1.8

0.79

0.00

114

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

551

1.44

2.57

5.9

6.9

68.34

70.20

0.23

427

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

3.97

2.54

1.6

1.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

106

771

1.37

2.50

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

8199

79065

1.04

2.50

5.5

5.8

3.52

3.64

ug/l

0.08

7296

71231

(3020618) Glucose [Moles/volume] in Synovial fluid

2.21

2.48

1.1

1.0

5.66

5.18

mmol/l

0.20

(4015189) Microbial culture of sputum

574

1.42

2.44

2.5

2.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

316

1.57

2.43

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.18

2.42

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

112

827

1.35

2.42

1.6

1.2

10.84

10.76

mm/h

0.02

112

827

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

219

1767

1.23

2.38

4.1

5.4

160.09

105.53

u/ml

0.35

593

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

150

1158

1.29

2.37

1.3

1.5

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

287

1.59

2.36

1.6

1.3

50.15

52.13

0.09

121

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

329

1.54

2.29

2.4

1.3

95.87

385.47

ng/l

0.57

208

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

20506

201598

1.05

2.25

6.3

5.9

2.47

2.64

mmol/l

130.49

19063

186789

(4146454) Self-monitoring of blood glucose

300

2515

1.19

2.21

3.1

2.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

308

1.55

2.21

1.1

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.84

2.18

4.0

2.2

6.19

3.22

mu/l

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.31

2.16

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2754

25960

1.06

2.14

5.1

5.0

33.18

32.62

1.62

1935

17190

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

4.25

2.13

1.0

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

158

1.76

2.11

2.1

1.6

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.76

2.11

1.2

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

151

1.77

2.10

5.1

3.3

14.41

11.66

0.25

(44806420) Estimation of glomerular filtration rate

248

2057

1.20

2.09

2.4

2.5

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

197

1.66

2.05

1.0

1.1

8.90

20.10

iu/ml

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

20161

198237

1.04

2.05

5.6

5.1

4.33

4.53

mmol/l

147.82

18818

184379

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20017

196828

1.04

1.98

5.5

5.0

1.39

1.44

mmol/l

47.15

18543

181872

(3001218) Citrate [Mass/time] in 24 hour Urine

2.79

1.98

1.6

1.5

294.33

414.13

mg/24h

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

138

1083

1.27

1.98

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

246

1.57

1.97

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

473

4150

1.13

1.94

1.2

1.1

2.44

1.98

u/ml

0.41

270

2276

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

601

1.35

1.93

1.8

1.9

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

4.51

1.93

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

4.51

1.93

1.0

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

119

1.83

1.92

1.0

1.00

0.23

u/ml

0.56

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

119

1.83

1.92

1.1

1.0

3.07

2.97

u/l

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.01

1.91

2.8

4.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.22

1.87

1.5

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

195

1.63

1.87

2.4

1.8

1.50

1.71

mg/l

0.43

166

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

325

2790

1.16

1.85

1.5

0.33

0.37

nmol/l

0.56

245

2114

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

291

1.50

1.82

1.3

1.2

21.06

20.55

mmol/l

0.27

245

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.01

1.81

1.0

0.03

0.16

u/ml

—

(3045462) Protein/Creatinine [Ratio] in Urine

308

1.48

1.80

4.3

4.8

103.09

213.95

mg/mmol

0.30

276

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.04

1.76

1.0

1.1

0.01

0.08

u/ml

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.04

1.76

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

278

1.50

1.75

2.1

2.9

0.67

0.53

u/field

0.39

278

(3017509) Phencyclidine [Presence] in Urine

192

1.60

1.72

2.4

1.4

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.92

1.70

1.0

1.1

—

22.42

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

764

1.29

1.67

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

558

1.33

1.65

1.4

1.3

36.62

36.66

0.00

377

(40759632) Porphyrins [Mass/mass] in Stool

3.13

1.64

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

161

1317

1.21

1.64

2.1

1.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

407

3583

1.13

1.64

1.1

4.88

5.01

u/ml

0.05

221

1948

(3050129) First trimester maternal screen panel - Serum or Plasma

438

4867

0.89

1.64

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

457

1.37

1.63

1.8

1.4

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.42

1.63

2.4

1.4

1.47

2.09

mmol/24h

—

(1617658) Protocol used for examination of sentinel lymph nodes

107

1336

0.79

1.62

1.0

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

559

5016

1.11

1.62

1.8

1.9

200.32

198.39

pmol/l

0.16

521

4737

(3020650) Glucose [Presence] in Urine

707

1.29

1.62

1.9

1.6

0.03

0.04

estimate

0.07

707

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

151

1.64

1.55

5.2

5.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

369

1.40

1.55

1.1

1.2

1.66

8.51

u/ml

1.89

251

(21494567) Legionella sp IgM Ab [Presence] in Serum

159

1.62

1.54

1.1

—

0.21

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

144

1.65

1.53

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

404

1.38

1.52

1.1

0.69

0.83

umol/24h

0.36

187

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

132

1069

1.23

1.51

1.1

1.10

1.09

u/l

0.07

444

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.84

1.49

2.3

2.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

104

822

1.26

1.49

1.1

8.94

8.53

u/ml

0.04

146

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

224

1.51

1.48

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

571

1.30

1.44

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

251

2162

1.15

1.44

1.3

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

242

1.48

1.44

1.3

1.2

6.38

6.46

mmol/l

0.02

110

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

283

1.44

1.43

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.48

1.43

1.0

1.1

1700.00

2032.86

titre

—

(3050794) Legionella sp Ab [Presence] in Serum

194

1.53

1.43

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

124

1.68

1.43

1.3

0.06

0.07

g/l

0.32

(3005011) Chlamydia sp Ab [Titer] in Serum

270

1.43

1.36

1.7

1.6

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

270

3037

0.88

1.30

3.8

3.7

42.43

37.80

u/ml

0.22

263

2938

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

199

1.50

1.30

1.0

1.1

0.16

1.07

u/ml

0.91

(3002523) Influenza virus A Ag [Presence] in Specimen

371

3305

1.12

1.29

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

154

1290

1.19

1.29

1.1

17.08

19.78

u/ml

0.30

481

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

115

937

1.22

1.29

1.3

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.08

1.29

1.2

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

371

3307

1.11

1.28

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.33

1.28

1.1

1.3

1.51

2.10

g/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

376

3355

1.11

1.28

1.1

17.69

16.70

au/ml

0.08

740

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.76

1.27

1.2

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

316

1.38

1.27

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

267

1.41

1.24

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

387

3465

1.11

1.24

1.1

1.20

1.07

u/ml

0.18

185

1602

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

404

1.33

1.22

1.6

1.2

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.84

1.21

1.1

0.03

0.05

g/l

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

203

1.47

1.20

1.0

1.1

0.07

2.94

u/ml

0.72

(3046861) Legionella sp Ag [Presence] in Urine

147

1.55

1.19

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.29

1.17

1.3

1.0

—

(40768793) Breast Pathology biopsy report

404

4407

0.91

1.16

1.4

1.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.73

1.16

1.0

1.1

303.00

268.24

nmol/l

0.43

(3004446) Plasmodium sp identified in Blood by Light microscopy

181

1.48

1.14

2.6

2.7

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.32

1.11

1.6

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

182

1.47

1.11

1.0

1.1

0.28

0.52

u/ml

0.31

(3000285) Sodium [Moles/volume] in Blood

454

1.29

1.11

1.3

138.14

138.34

mmol/l

0.16

379

(3016031) Almond IgE Ab [Units/volume] in Serum

142

1.54

1.10

1.0

1.1

0.34

1.12

u/ml

1.62

(3010726) Horse dander IgE Ab [Units/volume] in Serum

370

3334

1.10

1.09

1.1

2.73

1.70

u/ml

0.66

210

1772

(3005082) Progesterone [Moles/volume] in Serum or Plasma

833

0.80

1.07

1.4

1.5

23.98

35.23

nmol/l

2.84

760

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

276

1.37

1.06

1.1

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.80

1.06

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

177

1.46

1.03

1.1

5.48

0.70

u/ml

0.50

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

1.94

1.03

2.3

1.9

192.09

247.31

ug/l

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.69

1.02

1.0

1.1

159.22

210.98

pmol/l

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

228

1.39

1.01

1.2

8.91

8.96

mg/l

0.01

209

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

296

1.34

1.01

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

715

6648

1.07

1.01

1.8

42.39

42.72

nmol/l

0.13

690

6469

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

538

4952

1.08

1.00

1.4

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

984

0.83

0.97

1.5

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.70

0.96

1.2

1.1

0.09

0.13

g/l

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.96

0.0

7.9

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.79

0.96

1.4

1.2

26.61

57.71

umol/24h

0.70

(3014599) Egg white IgE Ab [Units/volume] in Serum

135

1155

1.16

0.95

1.1

4.81

7.96

u/ml

0.30

337

(3046682) IgA [Presence] in Skin by Immunofluorescence

2.13

0.91

1.0

—

(3032641) Amino acids panel - Urine

2.13

0.91

1.3

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

126

1.50

0.88

1.7

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

201

1.38

0.87

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

230

2056

1.11

0.85

1.4

1.5

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.57

0.84

1.5

1.6

0.40

0.20

u/l

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.71

0.84

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

298

2702

1.10

0.83

1.1

5.81

5.21

u/ml

0.20

149

1243

(40761995) Spermatozoa Progressive [#/volume] in Semen

386

0.75

0.83

3.8

3.1

40.55

44.47

0.46

386

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

385

0.75

0.82

7.6

6.3

8.62

8.57

0.02

385

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

476

1.23

0.81

1.1

1.2

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.69

0.80

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2014

19356

1.04

0.79

2.4

2.3

12.65

12.62

nmol/l

0.05

1756

17302

(4094501) Cardiovascular stress test using bicycle ergometer

606

5662

1.06

0.79

1.1

—

(46236302) HLA-C [Type] by High resolution typing

1.63

0.79

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.53

0.78

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

155

1.41

0.78

1.2

1.3

0.50

0.52

iu/ml

0.03

(4211845) Urine protein measurement

127

1106

1.14

0.75

3.6

3.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

264

0.71

0.73

1.3

2.4

7.88

7.52

mmol/l

—

113

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

117

1017

1.14

0.72

1.1

—

0.65

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.59

0.71

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

158

1.38

0.71

1.0

1.1

0.04

0.30

u/ml

1.81

158

(3024869) Neuronal Ab [Presence] in Serum

405

1.23

0.69

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

133

1174

1.12

0.66

6.1

7.2

14.15

102.99

ug/l

2.10

776

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

596

5612

1.05

0.64

1.5

1.4

—

(3041184) Isoniazid [Presence] in Urine

1.71

0.63

1.4

2.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

128

1.40

0.63

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

456

1.20

0.63

1.2

—

(3025577) Chromium [Mass/volume] in Blood

151

1349

1.11

0.62

2.3

2.1

2.55

2.26

ug/l

0.36

129

1115

(3029396) Erythrocyte agglutination [Presence] in Blood

448

1.20

0.61

2.9

2.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

854

1.14

0.61

1.5

1.9

118.27

811.48

pmol/l

0.63

151

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

146

1.36

0.61

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

310

2866

1.07

0.61

1.1

4.94

4.15

u/ml

0.36

167

1464

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.54

0.60

1.0

1.1

0.01

1.25

u/ml

0.83

(3015076) Soybean IgE Ab [Units/volume] in Serum

116

1024

1.12

0.60

1.1

0.74

1.38

u/ml

0.48

292

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.50

0.58

1.0

—

(40763590) HLA-DQ beta [Type]

1.52

0.57

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.47

0.56

1.5

1.1

27.48

32.16

mg/24h

—

(3022670) pH of Venous cord blood

1.47

0.56

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

115

1020

1.12

0.56

3.7

3.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

290

1.23

0.56

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

154

1389

1.10

0.55

2.2

2.1

4.64

3.62

ug/l

0.56

144

1284

(1002224) Polysomnography panel

846

8726

0.96

0.55

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

255

2718

0.93

0.54

1.5

60.62

59.66

ug/l

0.13

255

2718

(40760409) HLA-A [Type] by High resolution

1.50

0.54

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.50

0.54

1.0

—

(40760410) HLA-B [Type] by High resolution

1.50

0.54

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

176

1.30

0.53

8.2

5.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.40

0.52

1.0

1.14

0.46

u/ml

—

(3013862) HLA-DP [Type]

1.48

0.51

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

114

1018

1.11

0.51

5.2

6.1

55.00

4135.94

u/ml

0.59

175

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.37

0.50

1.3

1.0

0.96

0.04

u/ml

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

152

1.31

0.49

1.3

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

593

1.14

0.46

1.1

1.0

11.88

11.13

u/ml

0.08

368

(3025130) Human papilloma virus identified in Specimen

273

2551

1.06

0.44

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

401

0.84

0.43

1.1

19.24

34.41

iu/ml

2.04

401

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.44

0.42

1.2

1.1

0.10

0.05

mg/l

—

(3032868) Hemoglobin electrophoresis panel in Blood

174

1.25

0.42

1.7

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

271

0.81

0.42

1.4

2.4

—

(3051101) Glucose [Moles/volume] in Cord blood

412

1.16

0.42

4.6

5.8

9.15

8.59

mmol/l

0.22

412

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

259

2423

1.06

0.42

1.1

0.61

0.47

u/ml

0.23

104

819

(40765089) Chromosome analysis panel - Blood by G-banded

590

0.87

0.41

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

211

1.22

0.41

1.1

3.80

5.14

u/ml

0.13

170

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

219

2040

1.07

0.41

1.2

1.3

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.46

0.40

1.6

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

140

1.28

0.40

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

489

1.14

0.39

1.3

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

634

6512

0.97

0.39

1.6

1.7

5.41

4.45

mg/l

0.54

510

4836

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.3

—

5.83

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.39

0.0

1.3

—

13.92

—

(3034614) HLA Ag [Interpretation]

1.38

0.38

1.6

1.1

—

(3022475) Manganese [Moles/volume] in Blood

112

0.71

0.37

1.3

0.13

0.16

umol/l

—

112

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

161

1.23

0.35

2.9

97.53

54.25

pmol/l

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.38

0.34

1.0

1.1

290.00

282.86

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

392

1.14

0.34

1.5

1.3

—

(3049233) Organic acids panel - Urine

1.35

0.34

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.33

0.32

1.0

143.82

165.91

g/l

1.85

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

160

1491

1.07

0.32

1.0

323.17

331.00

ng/l

0.12

117

1054

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

376

1.13

0.32

1.6

1.8

0.19

0.18

nmol/l

0.10

273

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

139

1472

0.94

0.31

1.4

1.3

167.59

175.00

pmol/l

0.16

139

1472

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.36

0.31

1.0

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

160

1494

1.06

0.31

1.0

779.14

723.60

ng/l

0.94

113

1020

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

173

1.20

0.30

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

160

1497

1.06

0.30

1.0

37.19

41.78

ng/l

0.85

116

1038

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2243

21955

1.01

0.27

1.6

—

6.25

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

771

1.08

0.27

1.4

1.8

3.55

2.71

u/ml

0.23

223

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

139

1.21

0.27

1.1

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.71

0.26

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.66

0.25

2.4

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

224

1.15

0.25

1.1

0.16

3.51

u/ml

2.92

183

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

318

1.12

0.24

1.1

1.3

33.23

44.03

mg/l

0.79

271

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

179

0.83

0.24

1.2

1.1

87.47

99.75

titre

0.32

179

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

136

0.80

0.24

1.0

—

(40758358) Immune stain study

0.73

0.24

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

236

1.14

0.22

1.1

1.0

18.54

6.98

u/ml

0.38

236

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.21

0.0

1.1

—

(42870560) Thyrotropin [Units/volume] in Cord blood

218

1.14

0.21

1.0

10.49

8.29

mu/l

0.67

189

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

134

1.18

0.21

1.1

2.52

8.12

u/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

259

2483

1.04

0.21

1.4

1.3

7.42

7.40

mmol/l

0.05

226

2140

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

181

1.15

0.20

4.3

2.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.27

0.20

1.0

1.1

1.33

3.02

—

(40760512) CD34 cells/cells in Bone marrow

0.00

0.20

0.0

1.4

—

(3010937) Rubella virus Ab [Presence] in Serum

113

0.79

0.20

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

118

1.18

0.17

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

109

1.18

0.17

1.0

1.1

1.42

1.28

mom

0.21

109

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

100

1.19

0.17

11.7

9.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

128

1.16

0.17

1.1

1.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8576

84770

1.01

0.16

2.1

1.9

1.37

1.34

mmol/l

2.40

7127

70850

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

110

1.17

0.16

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

212

0.89

0.15

1.3

1.2

5.92

6.03

mmol/l

0.22

212

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6347

63227

0.99

0.14

4.6

4.7

22.01

22.27

0.62

3093

32381

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

188

1.11

0.13

1.1

1.55

1.80

umol/24h

0.61

188

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

434

0.94

0.12

1.7

3.0

128.08

115.19

ng/l

0.26

228

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

208

1.10

0.12

1.1

—

(40762814) Titanium [Mass/volume] in Blood

383

1.06

0.11

2.7

2.4

3.16

3.52

ug/l

0.41

140

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

214

2171

0.98

0.11

1.3

1.5

2.96

3.99

ug/l

2.35

190

1910

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

278

1.07

0.10

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

105

1.13

0.10

1.5

533.31

505.50

nmol/l

0.05

105

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

230

1.08

0.10

1.2

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

337

0.94

0.09

1.4

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

344

3463

0.99

0.09

1.6

—

(3001556) Androgen free Index in Serum or Plasma

164

1.09

0.08

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.79

0.08

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.07

0.07

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1912

19043

1.00

0.06

1.6

1.5

—

7.64

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

120

0.91

0.06

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

871

0.98

0.05

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

0.93

0.04

1.1

—

(3006598) pH of Arterial cord blood

189

1.05

0.03

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

189

1.05

0.03

1.0

6.75

7.23

kpa

0.48

169

(3004959) Base excess in Arterial cord blood by calculation

189

1.05

0.03

1.0

0.36

-2.30

mmol/l

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

275

0.97

0.01

1.2

72.63

68.73

ug/l

0.17

275

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

125

1.03

0.00

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

100

0.99

0.00

1.4

1.1

—

(3024316) Viscosity of Plasma

112

0.97

0.00

1.5

1.9

1.50

1.74

mpas

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

185

1.02

0.00

1.0

3.36

3.51

kpa

0.21

165

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

384

1.01

0.00

1.7

2.12

3.02

ug/l

0.52

222

(4133840) Spirometry

525

1.00

0.00

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

577

1.00

0.00

1.9

1.5

0.51

0.52

e9/l

0.16

577

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3032940) Amino acids [Identifier] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

0.90

-0.00

1.0

—

(4038314) Semen analysis, post vasectomy

0.90

-0.00

1.0

1.3

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

149.40

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.6

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.94

-0.00

1.3

1.1

8.44

8.31

mmol/l

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.1

—

436.43

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

392.80

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHDIG and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_OTHDIG	2.017 [1.84, 2.22]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.058

During the follow-up period (1.1.1998 — 31.12.2019), 26481 out of 76257 females with K11_OTHDIG died.

Males

Parameter	HR [95% CI]	p-value
K11_OTHDIG	2.58 [2.33, 2.86]	< 0.001
Birth year	0.984 [0.98, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 32056 out of 79617 males with K11_OTHDIG died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHDIG.

N-year risk	Females	Males
1	0.153%	0.414%
5	0.951%	2.423%
10	2.477%	6.114%
15	5.118%	10.966%
20	8.6%	18.372%

Relationships between endpoints

↥

Index endpoint: K11_OTHDIG – Diseases of the digestive system

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diseases of the digestive system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints